{"numRecords":"582","DataElementQueryResults":[{"publicId":"2838551","version":"2","preferredName":"Clinical Trial Screening Failure Reason","preferredDefinition":"Text explanations the failure of an individual to meet screen requirements for a clinical trial.","longName":"CLIN_TRL_SC_FAIL_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"402ECE27-39F8-2913-E053-F662850ADA7F","latestVersionIndicator":"Yes","beginDate":"2016-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-31","modifiedBy":"LISU","dateModified":"2020-05-28","changeNote":"Curated to support Duke University adoption of C3D. v2.0 released to replace v1.0 in order to extend the maximum field length from 30 to 10 characters.10.31.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3206040","version":"1","preferredName":"Peripheral Blood Stem Cell Transplantation Nucleated Blood Cell Harvest Procedure Value","preferredDefinition":"Numeric value to represent the total number of nucleated cells harvested for peripheral blood stem cell transplantation.","longName":"PBSC_NUC_HARV_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-4EB9-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-21","modifiedBy":"REEVESD","dateModified":"2014-05-16","changeNote":"Curated for Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3447899","version":"1","preferredName":"Radiation Therapy Salvage Therapy Occurrence Indicator","preferredDefinition":"Text term to signify whether radiation therapy was administered as treatment for cancer unresponsive to other treatments (salvage therapy).","longName":"RT_SALV_TX_OCC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF14486A-DEB5-95BC-E040-BB89AD4305C8","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-02","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640696","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Forming Thoughts Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about an individual's trouble forming thoughts.","longName":"COGA1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7708-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640697","version":"1","preferredName":"FACT-Cognitive Questionnaire Slow Thinking Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual's thinking has been slow.","longName":"COGA3_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7727-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640699","version":"1","preferredName":"FACT-Cognitive Questionnaire Finding Known Location Problem Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had trouble finding a familiar place.","longName":"COGM9_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0967B97-7765-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640700","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Remembering Items Placement Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had trouble remembering where things were put.","longName":"COGM10_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7784-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640701","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Remembering New Information Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had trouble remembering new information.","longName":"COGM12_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-77A9-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640702","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Recall Item Name Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had trouble recalling a name of an object while talking to someone.","longName":"COGV13_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-77C8-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640703","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Finding Correct Words Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had trouble finding the right word(s) to express himself/herself.","longName":"COGV15_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-77EA-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640704","version":"1","preferredName":"FACT-Cognitive Questionnaire Use Wrong Word Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has used the wrong word referring to an object.","longName":"COGV16_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7809-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640705","version":"1","preferredName":"FACT-Cognitive Questionnaire Trouble Speaking Meaning Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has trouble saying what is meant in conversations.","longName":"COGV17B_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7828-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640707","version":"1","preferredName":"FACT-Cognitive Questionnaire Attention Concentrate to Avoid Mistake Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has to work really hard to pay attention or make a mistake.","longName":"COGF23_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0967B97-7866-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640708","version":"1","preferredName":"FACT-Cognitive Questionnaire Forgot People Name Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has forgotten names of people soon after being introduced.","longName":"COGF24_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0967B97-7885-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640710","version":"1","preferredName":"FACT-Cognitive Questionnaire Work Harder Keep Up Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking about if an individual has had to work harder than usual to keep track of what he/she is doing.","longName":"COGC31_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-78C3-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640711","version":"1","preferredName":"FACT-Cognitive Questionnaire Slower Usual Thinking Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual's thinking has been slower than usual.","longName":"COGC32_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-78E2-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640712","version":"1","preferredName":"FACT-Cognitive Questionnaire Expression Problem Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had to work harder than usual to express himself/herself clearly.","longName":"COGC33A_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0967B97-7901-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640713","version":"1","preferredName":"FACT-Cognitive Questionnaire Written Documentation Use Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had to use written lists more often than usual in order to not forget things.","longName":"COGC33C_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-7920-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640714","version":"1","preferredName":"FACT-Cognitive Questionnaire Interruption Problem Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had trouble keeping track of things after an interruption.","longName":"COGMT1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0967B97-793F-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640715","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Change Activity Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had trouble shifting back and forth between activities.","longName":"COGMT2_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-795E-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640716","version":"1","preferredName":"FACT-Cognitive Questionnaire Other Memory Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had other people notice his/her trouble remembering information.","longName":"COGO1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-797D-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640717","version":"1","preferredName":"FACT-Cognitive Questionnaire Other Speak Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had other people notice his/her trouble speaking clearly.","longName":"COGO2_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-799C-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640718","version":"1","preferredName":"FACT-Cognitive Questionnaire Other Speak Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had other people notice his/her trouble thinking clearly.","longName":"COGO3_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-79BB-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640719","version":"1","preferredName":"FACT-Cognitive Questionnaire Other Confusion Score Frequency 5 Point Likert Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has had other people notice he/she seemed confused.","longName":"COGO4_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0967B97-79DA-48B1-E040-BB89AD434E23","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640738","version":"1","preferredName":"FACT-Cognitive Questionnaire  Concentration Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been able to concentrate","longName":"COGPC1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D098E4F8-0046-340D-E040-BB89AD435627","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640739","version":"1","preferredName":"FACT-Cognitive Questionnaire Term Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been able to bring to mind words while talking to someone.","longName":"COGPV1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D098E4F8-0086-340D-E040-BB89AD435627","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640740","version":"1","preferredName":"FACT-Cognitive Questionnaire Memory Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been able to remember things, like where a wallet or keys were left.","longName":"COGPM1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D098F135-1F10-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640741","version":"1","preferredName":"FACT-Cognitive Questionnaire Memory Task Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been able to remember to do things, like take medicine or buy something that was needed.","longName":"COGPM2_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D098F135-1F3F-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640742","version":"1","preferredName":"FACT-Cognitive Questionnaire Attention Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been able to pay attention and key track of activities without extra effort.","longName":"COGPF1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D098F135-1F6E-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640743","version":"1","preferredName":"FACT-Cognitive Questionnaire Mental Capacity Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual feels his/her mind is as sharp as it always has been.","longName":"COGPCH1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D098F135-1F8D-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640744","version":"1","preferredName":"FACT-Cognitive Questionnaire Memory Intact Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual feels his/her memory is as good as it has always been.","longName":"COGPCH2_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D098F135-1FAC-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640745","version":"1","preferredName":"FACT-Cognitive Questionnaire Change Task Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual feels he/she can shift between activities that require thinking.","longName":"COGPMT1_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D098F135-1FCB-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640746","version":"1","preferredName":"FACT-Cognitive Questionnaire Interruption Ability Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual feels he/she can keep track of what is happening even if interrupted.","longName":"COGPMT2_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D098F135-1FEA-093F-E040-BB89AD4314A6","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640846","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Impact Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual has been upset by their problems.","longName":"COGQ35_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D099AEF2-51A1-688F-E040-BB89AD430796","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640847","version":"1","preferredName":"FACT-Cognitive Questionnaire Problem Interference Impact Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual's problems have interfered with the ability to work.","longName":"COGQ37_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D099AEF2-51C0-688F-E040-BB89AD430796","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"CHILLIJ","dateModified":"2014-04-30","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640848","version":"1","preferredName":"FACT-Cognitive Questionnaire Interference Enjoyment Impact Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual's problems have interfered with the ability to do enjoyable things.","longName":"COGQ38_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D099BAD9-B2DA-BAD6-E040-BB89AD434943","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3640849","version":"1","preferredName":"FACT-Cognitive Questionnaire Interference Quality of Life Impact Past 7 Days How Important Score Five Point Scale","preferredDefinition":"Numeric response to a questionnaire item asking if an individual's problems have interfered with the his/her quality of life.","longName":"COGQ41_FACTCOG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D099AEF2-51DF-688F-E040-BB89AD430796","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-11","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeNote":"4/30/14 Moved to DCI context; associated CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3835528","version":"1","preferredName":"Study Treatment Medication of Interest Name","preferredDefinition":"Text term for the name of an agent used in a clinical trial study.","longName":"MED_INTEREST_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2D696CA-935D-9226-E040-BB89AD4309FC","latestVersionIndicator":"Yes","beginDate":"2013-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-31","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for Pharmacovigilance study per request by T.Locklear. mc 7/31/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3835535","version":"1","preferredName":"Informed Consent for Data Collection Obtained Indicator","preferredDefinition":"Indicator of whether or not the consent was obtained to collect data on a patient or if the Institutional Review Board granted a waiver.","longName":"CONSENT_OBT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2D6CEE7-F3C1-43CF-E040-BB89AD437DFA","latestVersionIndicator":"Yes","beginDate":"2013-07-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-31","modifiedBy":"FINCHAMB","dateModified":"2023-06-08","changeNote":"Created for DCRI Pharmacovigilant study per request by T.Locklear. mc 7/31/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3838371","version":"1","preferredName":"Australia-Modified Karnofsky Performance Status Score","preferredDefinition":"Numeric score of the Australia-Modified Karnofsky Performance Scale that measures the functional capabilities of a person.","longName":"PT_AKPS_SCORE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"AKPS:Australia-modified Karnofsky Performance Status, Abernethy, A. P., Shelby-James, T., Fazekas, B. S., Woods, D. Currow, D. C., 2005","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3488D89-A3AB-4E65-E040-BB89AD435EB8","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-06","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI per request by T.Locklear. mc 8/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3838513","version":"1","preferredName":"Death Date Unknown Checkbox Indicator","preferredDefinition":"Checkbox indicator used when the death date is unknown.","longName":"DEATH_ DATE_UNKNOWN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3488D89-A47C-4E65-E040-BB89AD435EB8","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-06","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI per request by T.Locklear. mc 8/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852548","version":"1","preferredName":"Medication Addendum Question Baseline or Acute Past 24 Hours Take Any Medication Except the Study Drug for Vomiting Indicator","preferredDefinition":"A person's stated indication of whether or not they took any medication for vomiting, except the study drug, in the past 24 hours.","longName":"NVMAQ_BA_Q1A","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-25A6-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852549","version":"1","preferredName":"Medication Addendum Question Baseline or Acute Past 24 Hours Take Any Medication Except the Study Drug for Nausea Indicator","preferredDefinition":"A person's stated indication of whether or not they took any medication for nausea, except the study drug, in the past 24 hours.","longName":"NVMAQ_BA_Q3A","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-25C6-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852550","version":"1","preferredName":"Medication Addendum Question During Delayed Period Take Any Medication Except the Study Drug for Vomiting Indicator","preferredDefinition":"A person's stated indication of whether or not they took any medication for vomiting, except the study drug, on the second day during the first week of chemotherapy.","longName":"NVMAQ_D_Q1A","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-25E6-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852551","version":"1","preferredName":"Medication Addendum Question During Delayed Period Take Any Medication Except the Study Drug for Nausea Indicator","preferredDefinition":"A person's stated indication of whether or not they took any medication for nausea, except the study drug, on the second day during the first week of chemotherapy.","longName":"NVMAQ_Q3A","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-2606-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"MORENOC","dateModified":"2017-04-18","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852552","version":"1","preferredName":"Nausea Vomiting Risk Factor History of Motion Sickness Yes No Indicator","preferredDefinition":"The sensation that one is about to vomit._The reflex act of ejecting the contents of the stomach through the mouth._Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations._A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Disorder caused by motion, as sea sickness, train sickness, car sickness, air sickness, or SPACE MOTION SICKNESS. It may include nausea, vomiting and dizziness._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"NVRF_Q1A","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-2626-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852553","version":"1","preferredName":"Nausea Vomiting Risk Factor History of Pregnancy-Related Nausea and/or Vomiting Yes No Indicator","preferredDefinition":"The sensation that one is about to vomit._The reflex act of ejecting the contents of the stomach through the mouth._Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations._A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Nausea and/or vomiting co-occurring with pregnancy._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"NVRF_Q1B","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38F3887-87EA-564C-E040-BB89AD4322F6","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852571","version":"1","preferredName":"Nausea Vomiting Risk Factor History of Chemotherapy-Related Nausea and/or Vomiting Yes No Indicator","preferredDefinition":"The sensation that one is about to vomit._The reflex act of ejecting the contents of the stomach through the mouth._Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations._A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Nausea and/or vomiting co-occurring with a cycle of chemotherapy._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"NVRF_Q1C","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-2646-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852572","version":"1","preferredName":"Nausea Vomiting Risk Factor History of Other Difficulty with Nausea and/or Vomiting Indicator","preferredDefinition":"A person's stated indication of whether or not they have a history of other difficulties with nausea and/or vomiting.","longName":"NVRF_Q1D","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E38ECC4B-2666-DC84-E040-BB89AD434ED9","latestVersionIndicator":"Yes","beginDate":"2013-08-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-09","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852599","version":"1","preferredName":"Medication Addendum Question Baseline or Acute Past 24 Hours Take Any Medication Except the Study Drug for Vomiting Take Any Medication Except the Study Drug Reason","preferredDefinition":"The sensation that one is about to vomit._The reflex act of ejecting the contents of the stomach through the mouth._An appendage to an existing document that contains supplemental information. The parent document remains content is unaltered._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._A starting point to which things may be compared._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Having a severe and rapid onset of symptoms with short duration._A question about whether an individual took any medication, except the study drug, for vomiting in the past 24 hours._An explanation of the cause of some phenomenon or action.","longName":"NVMAQ_BA_QB","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-37A3-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852600","version":"1","preferredName":"Medication Addendum Question Baseline or Acute Past 24 Hours Take Any Medication Except the Study Drug for Nausea Reason","preferredDefinition":"A person's stated observation of the reason they took a medication for nausea, other than the study drug, in the past 24 hours.","longName":"MAQ_BA_TKMD_NAUS_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-37C3-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852601","version":"1","preferredName":"Medication Addendum Question During Delayed Period Take Any Medication Except the Study Drug for Vomiting Reason","preferredDefinition":"A person's stated observation of the reason they took a medication for vomiting, other than the study drug, on the second day during the first week of chemotherapy.","longName":"MAQ_DL_TKMD_VOM_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-37E3-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852602","version":"1","preferredName":"Medication Addendum Question During Delayed Period Take Any Medication Except the Study Drug for Nausea Take Any Medication Except the Study Drug Reason","preferredDefinition":"A person's stated observation of the reason they took a medication for nausea, other than the study drug, on the second day during the first week of chemotherapy.","longName":"MAQ_DL_TKMD_NAUS_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-3803-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852603","version":"1","preferredName":"Nausea Vomiting Risk Factor History of Alcohol Use Alcohol Consumption Frequency","preferredDefinition":"The sensation that one is about to vomit._The reflex act of ejecting the contents of the stomach through the mouth._Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations._A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Consumption of liquids containing ethanol, including the behaviors associated with drinking the alcohol._consumption of liquids containing ethanol; includes the behavior of drinking the alcohol._The number of occurrences of something within a given time period. (NCI)","longName":"NVRF_Q1E","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-3823-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3852604","version":"1","preferredName":"Nausea Vomiting Risk Factor History Smoking Status Type","preferredDefinition":"A person's stated observation of their smoking status.","longName":"NVRF_Q1F","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E39FF09F-3843-D627-E040-BB89AD431959","latestVersionIndicator":"Yes","beginDate":"2013-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-10","modifiedBy":"HARTLEYG","dateModified":"2013-08-22","changeNote":"Created for Duke U. Brain study per request by M.Leonard. mc 8/9/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883291","version":"1","preferredName":"Bladder V80 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a bladder site receiving at least 80 Gray (Gy) radiotherapy dose.","longName":"BLAD_V80GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8048B-E645-577D-E040-BB89AD43266F","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883292","version":"1","preferredName":"Bladder V70 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a bladder site receiving at least 70 Gray (Gy) radiotherapy dose.","longName":"BLAD_V70GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8048B-E664-577D-E040-BB89AD43266F","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883311","version":"1","preferredName":"Bladder V40 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a bladder site receiving at least 40 Gray (Gy) radiotherapy dose.","longName":"BLAD_V40GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8048B-E688-577D-E040-BB89AD43266F","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883315","version":"1","preferredName":"Rectum V80 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a rectum site receiving at least 80 Gray (Gy) radiotherapy dose.","longName":"RECT_V80GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8531B-89ED-E9F6-E040-BB89AD436C32","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883317","version":"1","preferredName":"Rectum V60 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a rectum site receiving at least 60 Gray (Gy) radiotherapy dose.","longName":"RECT_V60GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8531B-8A27-E9F6-E040-BB89AD436C32","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883322","version":"1","preferredName":"Rectum V40 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a rectum site receiving at least 40 Gray (Gy) radiotherapy dose.","longName":"RECT_V40GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8048B-E6A7-577D-E040-BB89AD43266F","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883324","version":"1","preferredName":"Left Femoral Head V50 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at the left femoral head site receiving at least 50 Gray (Gy) radiotherapy dose.","longName":"L_FEM_V50GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8531B-8A64-E9F6-E040-BB89AD436C32","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883325","version":"1","preferredName":"Right Femoral Head V50 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at the right femoral head site receiving at least 50 Gray (Gy) radiotherapy dose.","longName":"R_FEM_V50GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8531B-8A83-E9F6-E040-BB89AD436C32","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883327","version":"1","preferredName":"Bowel V50 Gray Percentage Value","preferredDefinition":"Numeric value for the critical organ volume at a bowel site receiving at least 50 Gray (Gy) radiotherapy dose.","longName":"BWL_HD_V50GY_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5F8531B-8AA2-E9F6-E040-BB89AD436C32","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3903149","version":"1","preferredName":"Clinical Study End Point Date","preferredDefinition":"The date on which the patient is determined to be off the study.","longName":"3903144v1.0:2018550v1.0","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6C05329-2E80-93BA-E040-BB89AD431251","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-19","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI per request by T.Locklear. mc 9/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3903150","version":"1","preferredName":"Clinical Study End Point Reason","preferredDefinition":"Text term that describes the reason that no further data are being collected for the patient.","longName":"3903144v1.0:3903145v1.0","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6C05329-2EA6-93BA-E040-BB89AD431251","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-19","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI per request by T.Locklear. mc 9/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3903163","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version Has Metastatic Solid Tumor Indicator","preferredDefinition":"Indicator to signify whether or not an individual has or had a metastatic solid tumor.","longName":"CCI_ METASTASES_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6C064D4-F441-4920-E040-BB89AD433B6F","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-19","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI per request by T.Locklear. mc 9/19/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3911933","version":"1","preferredName":"EPIC Quality of Life Sexual Intercourse Occurrence Assessment Scale","preferredDefinition":"Response to a question to assess or evaluate the occurrence of sexual intercourse, physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual's sense of well-being and ability to enjoy life.","longName":"EPIC_62","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7AD316E-FF28-BAA8-E040-BB89AD4349E7","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-01","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support use of EPIC QoL instrument for Duke clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3915154","version":"1","preferredName":"Laboratory Procedure Creatinine Clearance Result Cockcroft Gault Value","preferredDefinition":"Numeric representation for the creatinine clearance as determined by use of the Cockcroft-Gault equation.","longName":"2190034v1.0:3915153v1.0","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E82831F4-67A8-0218-E040-BB89AD43457F","latestVersionIndicator":"Yes","beginDate":"2013-10-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-07","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI Pharmacovigilance study per request by T.Locklear. mc 10/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3916376","version":"1","preferredName":"Pelvic Lymph Node Location Anatomic Site","preferredDefinition":"Text name of a lymph node within the pelvic region.","longName":"PLV_LN_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E854B4CF-2204-2979-E040-BB89AD437922","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Created to support Duke Cancer Institute Prostate cancer trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3938891","version":"1","preferredName":"Adverse Event Severity Grade Missing Value Reason","preferredDefinition":"Text term that describes the reason why an adverse event severity grade was not captured or recorded.","longName":"AE_GRADE_MVR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F5FF8B-4396-AE7C-E040-BB89AD430C5F","latestVersionIndicator":"Yes","beginDate":"2013-10-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-30","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 10/30/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945702","version":"1","preferredName":"Therapy Related Toxicity Description Text","preferredDefinition":"Text that describes the name of the toxicity.","longName":"TX_REL_TOX_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71051E-C315-9CF8-E040-BB89AD433955","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"MAESKEB","dateModified":"2016-02-10","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945703","version":"1","preferredName":"Naranjo Checklist Adverse Reaction Post Suspected Drug Administration Indicator","preferredDefinition":"Indicator that signifies whether or not an adverse drug reaction appeared after the suspected drug was given.","longName":"NARANJO_ADR_POST_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71051E-C33B-9CF8-E040-BB89AD433955","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945713","version":"1","preferredName":"Naranjo Checklist Adverse Reaction Improvement Post Discontinued Drug Or Antagonist Administered Indicator","preferredDefinition":"Indicator that signifies whether or not the adverse reaction improved when the drug was discontinued or specific antagonist was given.","longName":"NARANJO_ADR_IMPROV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71051E-C393-9CF8-E040-BB89AD433955","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945720","version":"1","preferredName":"Naranjo Checklist Adverse Reaction Alternate Cause Indicator","preferredDefinition":"Indicator that signifies whether or not an adverse reaction could have been caused by something other than administration of the drug.","longName":"NARANJO_ADR_ALT_CAUSE_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71D9CD-F41C-F051-E040-BB89AD431A15","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945731","version":"1","preferredName":"Naranjo Checklist Similar Adverse Reaction to Same/Similar Drug Administered Indicator","preferredDefinition":"Indicator that signifes whether or not the patient experienced a similar adverse reaction when the same or similar drug was previously given.","longName":"NARANJO_SIMILAR_ADR_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71D9CD-F462-F051-E040-BB89AD431A15","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3945738","version":"1","preferredName":"Naranjo Checklist Adverse Reaction Objective Evidence Confirmation Indicator","preferredDefinition":"Indicator that signifies whether or not the adverse reaction was confirmed by information proven true based on documentation, measurement or facts.","longName":"NARANJO_ADR_CONFIRM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Naranjo ADR Scale:Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71D9CD-F4AE-F051-E040-BB89AD431A15","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-11-05","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Created for DCRI study per request by T.Locklear. mc 11/5/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3948954","version":"1","preferredName":"Preoperative Biliary Stenting Performed Yes No Indicator","preferredDefinition":"Text term to signify whether preoperative placement of a plastic or metal tube into the bile duct was performed.","longName":"PREOP_BIL_STENT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EAA6D0E4-10CF-7772-E040-BB89AD4325F1","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-08","modifiedBy":"MORENOC","dateModified":"2016-08-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3951975","version":"1","preferredName":"Surgery Event Additional Surgical Procedure Indicator","preferredDefinition":"The yes/no response regarding whether a patient received additional surgical procedures aside from the main procedure during a planned surgical event.","longName":"SUR_EVN_ADD_PROC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB17989F-F2DB-DC27-E040-BB89AD437B72","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCC_GI_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3951993","version":"1","preferredName":"Hospital Admission Event Repeat Occurrence Indicator","preferredDefinition":"The yes/no response regarding whether a patient re-entered a medical institution after being dismissed for a primary event.","longName":"HOS_ADM_REP_OCC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB17989F-F30D-DC27-E040-BB89AD437B72","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"MORENOC","dateModified":"2017-09-25","changeNote":"DCC_GI SURG_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3951994","version":"1","preferredName":"Hospital Admission Event Repeat Occurrence Date","preferredDefinition":"The date a patient re-entered a medical institution after being dismissed for a primary event.","longName":"HOS_ADM_REP_OCC_DATE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB17989F-F32D-DC27-E040-BB89AD437B72","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"MORENOC","dateModified":"2017-09-25","changeNote":"DCC_GI SURG_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3952013","version":"1","preferredName":"Postoperative Assessment Date","preferredDefinition":"The date that a patient's status was assessed after having surgery.","longName":"POST_OP_ASMT_DATE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB17989F-F35F-DC27-E040-BB89AD437B72","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCC_GI SURG_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3952051","version":"1","preferredName":"Superficial Surgical Incision Site Infection Indicator","preferredDefinition":"The yes/no response regarding whether the patient developed superficial surgical site infection within 30 days after the operation where the infection involved only skin or subcutaneous tissue of the incision.","longName":"SUP_SRG_INC_INF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB19635F-E1A3-05CB-E040-BB89AD433595","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURG_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3952071","version":"1","preferredName":"Surgical Site Infection Indicator","preferredDefinition":"The yes/no response regarding whether an infection has developed at the incision site within 30 days after surgery.","longName":"SRG_SIT_INF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB19635F-E1EB-05CB-E040-BB89AD433595","latestVersionIndicator":"Yes","beginDate":"2013-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-13","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCC_GI SURG_ghd_11.13.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953097","version":"1","preferredName":"Superficial Incision Surgical Site Infection Characteristic Type","preferredDefinition":"The class of infections that occur within 30 days after surgery where the infection involves only skin or subcutaneous tissue of the incision.","longName":"SUP_INC_SSI_CHAR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E829-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953111","version":"1","preferredName":"Deep Incision Surgical Site Infection Indicator","preferredDefinition":"The yes/no response regarding whether a deep incision surgical site infection has occurred within 30 days after a surgery and consists of infection related to the operation and infection involved deep soft tissues of the incision.","longName":"DP_INC_SSI_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E849-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953112","version":"1","preferredName":"Deep Incision Surgical Site Infection Characteristic Type","preferredDefinition":"The characteristics that identify a deep incisional surgical site infection that occurs within 30 days after a surgery that involves deep soft tissues.","longName":"DP_INC_SSI_CHAR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EB430DDD-E86F-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953113","version":"1","preferredName":"Surgical Organ or Space Surgical Site Infection Indicator","preferredDefinition":"The yes/no response regarding whether an organ space surgical site infection occurred at the surgical site within 30 days after the procedure and appears to be related to the operation.  The infection can involve any part of the anatomy (for example, organs or spaces), other than the incision, which was opened or manipulated during an operation.","longName":"SRG_ORG_SPC_SSI_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E88F-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"MORENOC","dateModified":"2016-05-09","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953114","version":"1","preferredName":"Surgical Organ or Space Surgical Site Infection Characteristic Type","preferredDefinition":"The characteristics that identify an organ space surgical site infection that occurs within 30 days after a procedure and appears to be related to the operation.  The infection can involve any part of the anatomy (for example, organs or spaces), other than the incision, which was opened or manipulated during an operation.","longName":"ORG_SPC_SSI_CHAR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E8AF-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953115","version":"1","preferredName":"Gastrointestinal Surgical Procedure Type","preferredDefinition":"The list of surgeries that pertain to the stomach and intestines and a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.","longName":"GI_SRG_PROC_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E8CF-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953116","version":"1","preferredName":"Gastrointestinal Biopsy Procedure Other Specify Text","preferredDefinition":"Free text that describes other types of gastrointestinal biopsies that have not been previously listed.","longName":"GI_BIO_OTH_SPEC_TEXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB430DDD-E8EF-FF08-E040-BB89AD437573","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953131","version":"1","preferredName":"Gastrointestinal Secondary Surgical Procedure Type","preferredDefinition":"The list of secondary surgeries that pertain to the stomach and intestines and a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue. These surgeries are performed in addition to the primary surgical procedure.","longName":"GI_SEC_SRG_PROC_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB4642F5-1310-2E6D-E040-BB89AD434826","latestVersionIndicator":"Yes","beginDate":"2013-11-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-16","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953132","version":"1","preferredName":"Gastrointestinal Secondary Surgical Procedure Other Specify Text","preferredDefinition":"Free text that describes other types of secondary gastrointestinal surgical procedures that have not been previously listed.","longName":"GI_SEC_SRG_OTH_TEX","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB4642F5-1330-2E6D-E040-BB89AD434826","latestVersionIndicator":"Yes","beginDate":"2013-11-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-16","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd.11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3953133","version":"1","preferredName":"Injury Classification Type","preferredDefinition":"The classes of wounds that based on the wound's level of contamination allowing health care professionals to predict the risk of infections and wound healing outcomes.","longName":"INJ_CLASS_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB4642F5-1350-2E6D-E040-BB89AD434826","latestVersionIndicator":"Yes","beginDate":"2013-11-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-16","modifiedBy":"REEVESD","dateModified":"2013-12-10","changeNote":"DCI_GI SURGERY_ghd_11.15.13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038051","version":"1","preferredName":"Prostate Quality of Life Awakening Urination Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes related to waking up to excrete urine from the bladder due to interference from symptoms of prostate cancer.","longName":"EPIC_32","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED81878-CCFF-AC81-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2013-12-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038052","version":"1","preferredName":"Prostate Quality of Life Defecation Urgency Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with increased urge for expelling feces from the rectum due to interference from symptoms of prostate cancer.","longName":"EPIC_49","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED81878-CD26-AC81-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2013-12-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038053","version":"1","preferredName":"Prostate Defecation Frequency Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with increased incidences for expelling feces from the rectum due to interference from symptoms of prostate cancer.","longName":"epic_50","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED81878-CD4D-AC81-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038071","version":"1","preferredName":"Prostate Anal Incontinence Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with loss of control of anal and rectal sphincters for defecation due to interference from symptoms of prostate cancer.","longName":"epic_52","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED93215-9F82-5292-E040-BB89AD433439","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038091","version":"1","preferredName":"Prostate Blood Feces Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with appearance of blood in the feces passed from the rectum due to interference from symptoms of prostate cancer.","longName":"epic_53","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED93215-9FA9-5292-E040-BB89AD433439","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038111","version":"1","preferredName":"Prostate Overall Libido Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent change in individual satisfaction regarding all areas of sexual desire, urge and ability to function due to interference from symptoms of prostate cancer.","longName":"epic_68","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED93215-9FD0-5292-E040-BB89AD433439","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038112","version":"1","preferredName":"Prostate Hot Flashes Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in ability to perform routine tasks of daily living due to interference from hot flash symptoms associated with prostate cancer and treatment.","longName":"epic_74","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED93215-9FF7-5292-E040-BB89AD433439","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038113","version":"1","preferredName":"Prostate Breast Swelling Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent a change in ability to perform routine tasks of daily living due to interference from symptoms of breast enlargement, swelling or soreness associated with prostate cancer.","longName":"epic_75","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EED93215-A01E-5292-E040-BB89AD433439","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038131","version":"1","preferredName":"Prostate Depression Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent a change in mental state with feelings of sadness which affect ability to perform routine tasks of daily living resulting from interference or effects of prostate cancer.","longName":"epic_77","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FDE3-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-13","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038132","version":"1","preferredName":"Prostate Fatigue Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent a change in energy level or fatigue associated with ability to perform routine tasks of daily living due to interference from symptoms associated with prostate cancer.","longName":"epic_78","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FE0A-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-13","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038133","version":"1","preferredName":"Prostate Weight Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent the affect of change in body weight on ability to perform routine tasks of daily living due to interference from symptoms associated with prostate cancer and treatment.","longName":"epic_79","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FE31-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-13","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038134","version":"1","preferredName":"Prostate Overall Urinary Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent changes in overall urinary tract function, control and daily habits  due to interference from symptoms of prostate cancer.","longName":"epic_34","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FE58-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038135","version":"1","preferredName":"Prostate Quality of Life Urine Leakage Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent a change in routine tasks of daily living due to interference from symptoms of unwanted discharge of urine from the bladder associated with prostate cancer and treatment.","longName":"epic_28","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EDF9-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038136","version":"1","preferredName":"Prostate Quality of Life Urine Pain Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent a change in routine tasks of daily living due to interference from symptoms of burning or pain with excreting urine from the bladder associated with prostate cancer.","longName":"epic_29","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EE20-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038137","version":"1","preferredName":"Prostate Overall Bowel Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in overall lower gastrointestinal tract function, bowel control and daily bowel habits due to interference from symptoms of prostate cancer.","longName":"epic_55","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FE7F-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038138","version":"1","preferredName":"Prostate Abdominal Pain Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent changes in routine activities of daily living due to discomfort of distress of the abdomen, pelvis or rectum cause by interference from symptoms of prostate cancer.","longName":"epic_54","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FEA6-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038139","version":"1","preferredName":"Prostate Quality of Life Urinary Frequency Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent changes in routines for daily living due to increase in urgency or occasions to excrete urine from the bladder due to interference from symptoms of prostate cancer.","longName":"epic_33","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDA7A32-FECD-F3FC-E040-BB89AD4373EF","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038140","version":"1","preferredName":"Prostate Quality of Life Incomplete Urination Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent changes in routine tasks of daily living due to interference from symptoms of difficulty to completely excrete urine due to interference from symptoms of prostate cancer.","longName":"epic_31","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EE47-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038141","version":"1","preferredName":"Prostate Quality of Life Hematuria Problem Past 4 Week Problem Severity Scale","preferredDefinition":"A numeric value to represent changes in routine tasks of daily living due to interference from symptoms of bleeding with expelling urine due to interference from symptoms of prostate cancer.","longName":"epic_30","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EE6E-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038142","version":"1","preferredName":"Prostate Diarrhea Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes relating to changes in bowel movements and diarrhea due to interference from symptoms of prostate cancer.","longName":"epic_51","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EE95-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038143","version":"1","preferredName":"Prostate Erection Function Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in the ability of the penis to function for hardening, enlarging and rising indicating arousal in males due to interference from symptoms of prostate cancer.","longName":"epic_66","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EEBC-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038144","version":"1","preferredName":"Prostate Ejaculation Function Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in the functional ability of the penis to release of semen during orgasm during sexual activity in males due to interference from symptoms of prostate cancer.","longName":"epic_67","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EEE3-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4038145","version":"1","preferredName":"Prostate Sex Behavior Libido Occurrence Problem Scale","preferredDefinition":"Numeric value to represent changes relating to changes in sexual desire due to interference from symptoms of prostate cancer.","longName":"epic_56","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EEDAA2FC-EF0A-88F0-E040-BB89AD431A91","latestVersionIndicator":"Yes","beginDate":"2013-12-31","endDate":null,"createdBy":"LEONARDM","dateCreated":"2013-12-31","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076069","version":"1","preferredName":"Prostate Quality of Life Urinary Leakage Symptom Past 4 Week Frequency Scale","preferredDefinition":"A numeric value to represent the interference from prostate cancer symptoms with normal urinary function causing escape of small amounts of urine from the bladder involuntarily.","longName":"epic_23","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-CF8E-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076071","version":"1","preferredName":"Prostate Quality of Life Hematuria Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in bleeding with expelling urine due to interference from symptoms of prostate cancer.","longName":"epic_24","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-CFB0-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076072","version":"1","preferredName":"Prostate Urine Pain Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent the burning or pain with excreting urine from the bladder associated with prostate cancer.","longName":"epic_25","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-CFE1-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076098","version":"1","preferredName":"Prostate Urinary Control Symptom Scale","preferredDefinition":"Numeric value to represent the interference from prostate cancer symptoms with normal urinary function causing loss of urine retention due to failed control of urinary bladder sphincters.","longName":"epic_26","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D009-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076099","version":"1","preferredName":"Prostate Adult Undergarment Use Scale","preferredDefinition":"Numeric value to represent the interference from prostate cancer symptoms with urinary function necessitating use of absorbent adult undergarments to compensate for failed control of bladder sphincter.","longName":"epic_27","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D031-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076100","version":"1","preferredName":"Prostate Awakening Urination Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes relating to waking up to excrete urine from the bladder due to interference from symptoms of prostate cancer.","longName":"epic_32","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D07D-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076101","version":"1","preferredName":"Prostate Defecation Urgency Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with increased urge for expelling feces from the rectum due to symptoms of prostate cancer.","longName":"epic_42","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D0B5-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076102","version":"1","preferredName":"Prostate Anal Incontinence Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with loss of control of anal and rectal sphincters for defecation due to symptoms of prostate cancer.","longName":"epic_43","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D0DD-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076103","version":"1","preferredName":"Prostate Diarrhea Problem Prostate Symptom Scale","preferredDefinition":"Numeric value to represent changes relating to changes in bowel movements and diarrhea due to interference from symptoms of prostate cancer.","longName":"epic_44","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D105-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076104","version":"1","preferredName":"Prostate Blood Feces Problem Symptom Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with appearance of blood in the feces passed from the rectum due to symptoms of prostate cancer.","longName":"epic_45","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D12D-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076105","version":"1","preferredName":"Prostate Defecation Pain Problem Prostate Symptom Scale","preferredDefinition":"Numeric value to represent changes in elimination of fecal material from the rectum and pain due to interference from symptoms of prostate cancer.","longName":"epic_46","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D155-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076107","version":"1","preferredName":"Prostate Defecation Frequency Problem Symptom Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function for expelling feces from the rectum due to symptoms of prostate cancer.","longName":"epic_47","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D17D-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076108","version":"1","preferredName":"Prostate Abdominal Pain Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in discomfort or distress of the abdomen, pelvis or rectum caused by interference from symptoms of prostate cancer.","longName":"epic_48","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D1A5-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076109","version":"1","preferredName":"Prostate Defecation Urgency Problem Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent changes in lower gastrointestinal tract function with increased urge for expelling feces from the rectum due to interference from symptoms of prostate cancer.","longName":"epic_49","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD0DC82-D1CD-73E5-E040-BB89AD433EBC","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076163","version":"1","preferredName":"Prostate Erection Function Sexual Activity Problem Scale","preferredDefinition":"Numeric value to represent changes in the ability of the penis to function for hardening, enlarging and rising indicating arousal in males due to interference from symptoms of prostate cancer.","longName":"epic_57","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C8F0-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076164","version":"1","preferredName":"Prostate Ejaculation Function Sexual Activity Problem Scale","preferredDefinition":"Numeric value to represent changes in the functional ability of the penis to release of semen during orgasm during sexual activity in males due to interference from symptoms of prostate cancer.","longName":"epic_58","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C918-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076165","version":"1","preferredName":"Prostate Erection Quality Prostate Erection Quality Scale","preferredDefinition":"Numeric value to represent the interference from prostate cancer symptoms with individual satisfaction regarding hardening, enlarging and rising of the penis indicating arousal in males.","longName":"epic_59","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C940-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076166","version":"1","preferredName":"Prostate Erection Occurrence Prostate Frequency Scale","preferredDefinition":"Numeric value to represent the interference from prostate cancer symptoms with rate of occurrence for hardening, enlarging and rising of the penis indicating arousal in males.","longName":"epic_60","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C968-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076167","version":"1","preferredName":"Prostate Erection Upon Awakening Function Symptom Scale","preferredDefinition":"Numeric value to represent changes in the ability of the penis to function for hardening, and waking from sleep, due to interference from symptoms of prostate cancer.","longName":"epic_61","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C990-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076168","version":"1","preferredName":"Prostate Sexual Intercourse Occurrence Assessment Scale","preferredDefinition":"Numeric value to represent the occurrence of sexual intercourse, physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual's sense of well-being and ability to enjoy life.","longName":"epic_62","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C9B8-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076169","version":"1","preferredName":"Prostate Sex Behavior Libido Assessment Scale","preferredDefinition":"Numeric value to represent a prostate patient's urge or desire for physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual's sense of well-being and ability to enjoy life.","longName":"epic_63","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-C9EB-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076170","version":"1","preferredName":"Prostate Overall Libido Function Sexual Activity Problem Scale","preferredDefinition":"Numeric value to represent a change in individual satisfaction regarding all areas of sexual desire, urge and ability to function due to interference from symptoms of prostate cancer.","longName":"epic_64","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CA13-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076171","version":"1","preferredName":"Sex Behavior Libido Occurrence Assessment Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent a person's urge or desire for physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual's sense of well-being and ability to enjoy life.","longName":"epic_65","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CA3B-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076172","version":"1","preferredName":"Prostate Hot Flashes Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in hot flash symptoms associated with prostate cancer and treatment.","longName":"epic_69","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CA86-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076173","version":"1","preferredName":"Prostate Breast Swelling Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent symptoms of breast enlargement, swelling or soreness associated with prostate cancer.","longName":"epic_70","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CAAE-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076174","version":"1","preferredName":"Prostate Depression Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent changes in mental state with feelings of sadness resulting from interference from effects of prostate cancer.","longName":"epic_71","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CAD6-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076175","version":"1","preferredName":"Prostate Fatigue Problem Past 4 Week Frequency Scale","preferredDefinition":"Numeric value to represent a change in energy level or fatigue associated with interference from symptoms associated with prostate cancer.","longName":"epic_72","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CAFE-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076176","version":"1","preferredName":"Prostate Weight Problem Change Scale","preferredDefinition":"Numeric value to represent a weight change associated with symptoms of prostate cancer and treatment.","longName":"epic_73","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CB26-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-12","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076177","version":"1","preferredName":"Patient Alopecia Assessment Past 4 Week Problem Severity Scale","preferredDefinition":"Numeric value to represent subjective reports made by the patient regarding a the lack or loss of hair from areas of the body where hair is usually found.","longName":"epic_76","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CB64-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-13","modifiedBy":"REEVESD","dateModified":"2014-03-07","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4076178","version":"1","preferredName":"Patient Satisfaction Therapy Assessment Scale","preferredDefinition":"Numeric value to represent a patient's assessment of satisfaction with disease treatment.","longName":"epic_80","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFD33F6C-CBAD-F695-E040-BB89AD4376AE","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-13","modifiedBy":"REEVESD","dateModified":"2014-01-14","changeNote":"Curated to support DCRI clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119551","version":"1","preferredName":"Laboratory Procedure CD4-Positive T-Lymphocyte T-Lymphocytes Regulatory Percentage Value","preferredDefinition":"Percentage value for the portion of T-regulatory cells positive for CD4 present in a sample of blood.","longName":"LAB_CD4_TSUP_PTG_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F11D299B-BD9F-2F36-E040-BB89AD431783","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-29","modifiedBy":"LEEW","dateModified":"2018-11-19","changeNote":"Curated to support Duke clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119892","version":"2","preferredName":"Enzyme-linked Immunosorbent Spot Assay Result Specimen Cell Count Total Value","preferredDefinition":"Numeric value representing an individual's cells in a single well that are incubated with a target antigen.","longName":"ELISPOT_TTL_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65998B38-7B63-3E7C-E053-F662850A45EC","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-19","modifiedBy":"HARTLEYG","dateModified":"2018-02-19","changeNote":"Curated to support Duke University trial; Versioned due to versioning of VD to extend max length from 4 to 6; ghd; 02.19.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119931","version":"2","preferredName":"Enzyme-linked Immunosorbent Spot Assay Total Minus BKG Antigen Result Cell Count Value","preferredDefinition":"Numeric value representing the total number of cells incubated with antigen minus the value for Bkg incubated wells.","longName":"ELISPT_M_BKG_CKK_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6599CE5C-9803-27C2-E053-F662850A2B75","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-19","modifiedBy":"HARTLEYG","dateModified":"2018-02-19","changeNote":"Curated to support Duke University trial; Versioned to support increase of max value length from 4 to 6; 02.19.18; ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119933","version":"1","preferredName":"Well Raw Value Count","preferredDefinition":"Numeric value for the number of cells counted within a single well.","longName":"WELL_CELL_TTL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F12137BF-BA16-6257-E040-BB89AD434C83","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-29","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4204354","version":"1","preferredName":"Hospital Discharge Delay Occurrence Yes No Indicator","preferredDefinition":"Text indicator to signify whether a patient's discharge from the hospital was delayed or later than originally planned.","longName":"HOSP_DC_DEL_OCC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F40AE481-95F9-0B0C-E040-BB89AD43154E","latestVersionIndicator":"Yes","beginDate":"2014-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-07","modifiedBy":"REEVESD","dateModified":"2014-03-10","changeNote":"Curated to support Duke clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4204355","version":"1","preferredName":"Hospital Discharge Delay Surgical Site Infection Relationship Occurrence Yes No Indicator","preferredDefinition":"Text indicator to signify whether a delay in a patient's discharge from the hospital was due to a surgical site infection.","longName":"HOSP_DEL_SSI_REL_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F40B9346-BC68-E958-E040-BB89AD4348B8","latestVersionIndicator":"Yes","beginDate":"2014-03-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-07","modifiedBy":"REEVESD","dateModified":"2014-03-10","changeNote":"Curated to support Duke clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4233200","version":"1","preferredName":"O6-methylguanine-DNA Methyltransferase Cytomegalovirus Laboratory Procedure Ordinal Result Category","preferredDefinition":"Text value from MGMT (O6-methylguanine-DNA methyltransferase) and CMV (cytomegalovirus) testing represented as an ordinal result.","longName":"MGMT_CMV_LAB_ORD_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F4F8A4BA-DCE2-5BB8-E040-BB89AD435135","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240231","version":"1","preferredName":"Prior Health Assessment SF 36 Item Survey Scale","preferredDefinition":"Coded response to a question about a person's health now as compared to one year ago.","longName":"SF36_2","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50160A7-0082-345D-E040-BB89AD431FDC","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial questionnaire","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240251","version":"1","preferredName":"Past 4 Week Reduced Work Physical Health Reason Yes No Coded Indicator","preferredDefinition":"Coded response to signify whether a person has reduced the amount of time spent on work or other activities as a result of physical health during the past four weeks.","longName":"SF36_13","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50160A7-028C-345D-E040-BB89AD431FDC","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240252","version":"1","preferredName":"Past 4 Week Reduced Productivity Physical Health Reason Yes No Coded Indicator","preferredDefinition":"Coded indicator to signify whether a person reported having accomplished less than he/she would have liked as a result of physical health during the past four weeks.","longName":"SF36_14","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50160A7-02CA-345D-E040-BB89AD431FDC","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240271","version":"1","preferredName":"Past 4 Week Limited by Health Physical Health Reason Yes No Coded Indicator","preferredDefinition":"Coded indicator to signify whether a person reported being limited in kind of work or other activities as a result of physical health during the past four weeks.","longName":"SF36_15","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50160A7-0308-345D-E040-BB89AD431FDC","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240272","version":"1","preferredName":"Past 4 Week Difficulty Work Physical Health Reason Yes No Coded Indicator","preferredDefinition":"Coded indicator to signify whether a person reports difficulty performing work or other activities due to physical health during the past four weeks.","longName":"SF36_16","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50160A7-0346-345D-E040-BB89AD431FDC","latestVersionIndicator":"Yes","beginDate":"2014-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-19","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240366","version":"1","preferredName":"Past 4 Week Reduced Work Emotional Problem Reason Yes No Coded Indicator","preferredDefinition":"Coded response to signify whether a person has reduced the amount of time spent on work or other activities as a result of emotional problems during the past four weeks.","longName":"SF36_17","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50B6368-9050-7BA6-E040-BB89AD4305BD","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240369","version":"1","preferredName":"Past 4 Week Reduced Productivity Emotional Problem Reason Yes No Coded Indicator","preferredDefinition":"Coded indicator to signify whether a person reported having accomplished less than he/she would have liked as a result of emotional problems during the past four weeks.","longName":"SF36_18","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50B6368-9081-7BA6-E040-BB89AD4305BD","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240392","version":"1","preferredName":"Past 4 Week Reduced Careful Emotion Problem Reason Yes No Coded Indicator","preferredDefinition":"Coded indicator to signify whether a person reported either not working or doing activities as carefully as usual as a result of emotional problems during the past four weeks.","longName":"SF36_19","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50B6368-9119-7BA6-E040-BB89AD4305BD","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"TSESU","dateModified":"2020-02-13","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4240428","version":"1","preferredName":"Past 4 Week Social Behavior Emotion Physical Interference 5 Point Likert Score","preferredDefinition":"Coded response to a person's reported interference in normal social activities during the past four weeks due to physical health or emotional problems.","longName":"SF36_20","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50C2FAF-03FA-1E01-E040-BB89AD433E73","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"TSESU","dateModified":"2019-12-19","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4241164","version":"1","preferredName":"Past 4 Week Body Pain Amount Likert 6 Point Scale","preferredDefinition":"Code to represent a person's report of the amount of bodily pain experienced in the previous four weeks.","longName":"SF36_21","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50BD3CF-4A09-4A03-E040-BB89AD4342B3","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4241720","version":"1","preferredName":"Past 4 Week Socializing Physical Health Emotional Problem Interference Assessment Duration Scale","preferredDefinition":"Numeric value to indicate how much of the time during the past four weeks a person had physical health or emotional problems interfere with social activities.","longName":"SF36_32","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F50E8948-F65E-57A3-E040-BB89AD436041","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4242052","version":"1","preferredName":"Person Sickness Pattern Occurrence True False Statement Scale","preferredDefinition":"Numeric value to indicate how true or how false a person finds a statement that he/she seems to become ill a little easier than other people do.","longName":"SF36_33","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F510CF0B-1F9A-FD3E-E040-BB89AD43550A","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4242053","version":"1","preferredName":"Person Health Comparison Assessment True False Statement Scale","preferredDefinition":"Numeric value to indicate how true or how false a person finds a statement that he/she is as healthy as anyone else.","longName":"SF36_34","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F510CF0B-1FD8-FD3E-E040-BB89AD43550A","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4242054","version":"1","preferredName":"Person Worse Health Expectation True False Statement Scale","preferredDefinition":"Numeric value to indicate how true or how false a person finds a statement that he/she is expecting for their level of health to decline.","longName":"SF36_35","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F510CF0B-2016-FD3E-E040-BB89AD43550A","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4242055","version":"1","preferredName":"Person Excellent Health Assessment True False Statement Scale","preferredDefinition":"Numeric value to indicate how true or how false a person finds a statement that he/she has excellent health.","longName":"SF36_36","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F510CF0B-2054-FD3E-E040-BB89AD43550A","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-20","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4265442","version":"1","preferredName":"Distance From Ventricle to Tumor Millimeter Value","preferredDefinition":"Numeric value representing the neuro anatomy distance from any ventricle in the brain to a specified primary tumor measured in millimeters (mm).","longName":"VENT_TUM_DIST_MM_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F69EE020-8EA2-FBD1-E040-BB89AD437E4C","latestVersionIndicator":"Yes","beginDate":"2014-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-09","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4319755","version":"1","preferredName":"Lesion Photograph Record Inclusion Yes No Indicator","preferredDefinition":"Text term to signify whether photographic documentation of site(s) of disease is included in a patient's record.","longName":"LES_PHOTO_INCL_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F96BF7D7-2839-F1D2-E040-BB89AD437EB8","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-15","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4319791","version":"1","preferredName":"Patient Disease Response Principal Investigator Approval Yes No Indicator","preferredDefinition":"Text term to signify whether the Principal Investigator for a clinical trial has reviewed and approved a patient's disease response to treatment.","longName":"DZ_RESP_PI_APPR_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F96C5265-6A8C-CAAB-E040-BB89AD4371A2","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-15","modifiedBy":"SARAHB","dateModified":"2018-04-05","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320218","version":"1","preferredName":"Biopsy Prior Therapy Field Inclusion Category","preferredDefinition":"Term to signify whether a biopsy was done on an area within or outside of a prior treatment field.","longName":"BX_PR_TX_FLD_INCL_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9754042-FB21-BDBA-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-15","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320230","version":"1","preferredName":"Melanoma Progressive Disease Anatomic Site","preferredDefinition":"Named location(s) of or within the body that assessed as anatomic sites of melanoma progressive disease.","longName":"MEL_PD_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9761764-923D-4A7C-E040-BB89AD432D4F","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-15","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320471","version":"1","preferredName":"Nonmelanomatous Progressive Disease Anatomic Site","preferredDefinition":"Named location(s) of or within the body that assessed as anatomic sites of non-melanoma progressive disease.","longName":"NONMEL_PD_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9832BDB-3DE6-1E26-E040-BB89AD432861","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320475","version":"1","preferredName":"Melanoma Disease Involvement Surgical Anatomic Site","preferredDefinition":"Named location(s) of or within the body surgically assessed as anatomic sites with melanoma involvement.","longName":"MEL_INV_SRG_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9832BDB-3E6E-1E26-E040-BB89AD432861","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320479","version":"1","preferredName":"Prior Radiation Therapy Melanoma Administered Yes No Indicator","preferredDefinition":"Text term to signify whether radiation therapy was previously given for melanoma involvement.","longName":"PR_RT_MEL_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9832BDB-3EF6-1E26-E040-BB89AD432861","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320484","version":"1","preferredName":"Prior Melanoma Radiation Therapy Radiation Field Anatomic Site","preferredDefinition":"Text description of a radiation field used deliver treatment to site(s) of melanoma.","longName":"PR_MEL_RT_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9842F2C-CDC1-FBFF-E040-BB89AD437039","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320493","version":"1","preferredName":"Disease Progression During Therapy Treatment Field Inclusion Category","preferredDefinition":"Term to signify whether disease progression occurred in an area within or outside of a prior treatment field.","longName":"DZ_PROG_RX_FLD__CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9851AB7-5031-E7C7-E040-BB89AD4358F2","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320536","version":"1","preferredName":"Prior Systemic Therapy Melanoma Administered Yes No Indicator","preferredDefinition":"Text term to signify whether systemic therapy was previously given for melanoma involvement.","longName":"4320525v1.0:3506068v1.0","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9851AB7-5057-E7C7-E040-BB89AD4358F2","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320576","version":"1","preferredName":"Melanoma Limb Therapy Name","preferredDefinition":"Name of chemotherapeutic procedure used to treat melanoma on one of the limbs.","longName":"MEL_LMB_TX_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F985806A-8E48-8230-E040-BB89AD4365D2","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-16","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330803","version":"1","preferredName":"Limb Available Vascular Volume Liter Value","preferredDefinition":"Value representing the available vascular space within a single limb of the body.","longName":"LMB_AVL_VAS_LVOL_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9EEDF8C-0F49-07A0-E040-BB89AD436D85","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330820","version":"1","preferredName":"Dose Infusion Perfusion Modification Reason","preferredDefinition":"Text term to describe the reason the dose of an agent associated with isolated limb infusion (ILI) or isolated limb perfusion (ILP) was changed.","longName":"DOSE_ILI_ILP_MOD_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F00373-1263-6F5B-E040-BB89AD436CC0","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330824","version":"1","preferredName":"Ideal Body Weight Correction Yes No Indicator","preferredDefinition":"Text term to signify whether a dose calculation is based on ideal body weight instead of actual body weight.","longName":"IDL_BDY_WT_CORR_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F16C61-3CCE-68BB-E040-BB89AD43774C","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330830","version":"1","preferredName":"Infusion Perfusion Drug Circulation Duration Minute Count","preferredDefinition":"Value for the length of time in minutes of drug exposure during a limb perfusion or infusion procedure.","longName":"INF_PERF_DUR_MIN_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F16C61-3D75-68BB-E040-BB89AD43774C","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330831","version":"1","preferredName":"Infusion Perfusion Drug Circulation Volume Milliliter Value","preferredDefinition":"Value for the volume drug in millimeters used during a limb perfusion or infusion procedure.","longName":"INF_PERF_DRG_VOL_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F16C61-3DAA-68BB-E040-BB89AD43774C","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330836","version":"1","preferredName":"Papaverine Administered Yes No Indicator","preferredDefinition":"Text term to signify whether Papaverine, an opiate alkaloid that is a direct-acting smooth muscle relaxant, was administered to a patient.","longName":"PAPV_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F16C61-3E39-68BB-E040-BB89AD43774C","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330841","version":"1","preferredName":"Isolated Limb Perfusion Infusion Procedure Tourniquet Identifier","preferredDefinition":"Identifier to distinguish between more than one tourniquets used during in isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedure.","longName":"ILP_ILI_TOURQ_ID","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F264E2-8799-FD85-E040-BB89AD436CC3","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330845","version":"1","preferredName":"Limb Ischemia Time Duration Minute Count","preferredDefinition":"Value for the length of time in minutes of ischemia induced by the application of a tourniquet during a limb perfusion or infusion procedure.","longName":"LMB_ISCH_DUR_MIN_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F264E2-87E1-FD85-E040-BB89AD436CC3","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330853","version":"1","preferredName":"Isolated Limb Perfusion Infusion Tourniquet Type","preferredDefinition":"Text identifier for a specific type of tourniquet using during an isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedure.","longName":"ILP_ILI_TOUNQ_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F264E2-88C9-FD85-E040-BB89AD436CC3","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330858","version":"1","preferredName":"Infusion Perfusion Procedure Limb Peak Temperature Celsius Scale Value","preferredDefinition":"Value for the highest temperature in Celsius degrees reached within a limb during an isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedure.","longName":"INF_LMB_PK_TEMP_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F35FA7-E38B-556A-E040-BB89AD4314D9","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330862","version":"1","preferredName":"Infusion Perfusion Procedure Limb Average Start Temperature Celsius Scale Value","preferredDefinition":"Value for the average starting temperature in Celsius degrees reached within a limb during an isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedure.","longName":"INF_LMB_SRT_TEMP_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F35FA7-E3D7-556A-E040-BB89AD4314D9","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330866","version":"1","preferredName":"Infusion Perfusion Procedure Limb Average End Temperature Celsius Scale Value","preferredDefinition":"Value for the average ending temperature in Celsius degrees reached within a limb during an isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedure.","longName":"INF_LMB_STP_TEMP_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F3A0B3-2DE3-4A5F-E040-BB89AD437328","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330871","version":"1","preferredName":"Melanoma Limb Palpable Pulse Yes No Indicator","preferredDefinition":"Text term to signify whether a pulse can be felt in the limb affected with melanoma.","longName":"MEL_LMB_PLP_PULS_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F407E1-6AF3-5DDD-E040-BB89AD4337D2","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330878","version":"1","preferredName":"Melanoma Tumor Burden Assessment Category","preferredDefinition":"Classification of the estimation of disease present in a patient with melanoma based on the number and size of lesions present.","longName":"MEL_TM_BDN_ASSMT_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F4692E-26C3-AE5A-E040-BB89AD43536F","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330883","version":"1","preferredName":"Excision Sentinel Lymph Node With Primary Neoplasm Excision Yes No Indicator","preferredDefinition":"Text term to signify whether a sentinel lymph node was removed at the same time as the primary tumor.","longName":"EXC_SENT_PRIM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F407E1-6C02-5DDD-E040-BB89AD4337D2","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4330888","version":"1","preferredName":"Excision Sentinel Lymph Node With Primary Neoplasm Result Positive Negative Not Applicable Category","preferredDefinition":"Classification of result of excision of primary tumor along with sentinel lymph node.","longName":"SENT_PRIM_RES_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9F407E1-6C7F-5DDD-E040-BB89AD4337D2","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke University melanoma clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4363119","version":"1","preferredName":"Laboratory Procedure Panel Category","preferredDefinition":"A group of laboratory test names that are performed together.","longName":"LAB_PANEL_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC4A9195-8272-C93F-E040-BB89AD4347B0","latestVersionIndicator":"Yes","beginDate":"2014-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-20","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4369283","version":"1","preferredName":"Treatment History Period Category","preferredDefinition":"Text classification of time periods relative to a person's current treatment.","longName":"TX_HX_PD_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FCB49283-4914-5B78-E040-BB89AD436EF0","latestVersionIndicator":"Yes","beginDate":"2014-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-06-25","modifiedBy":"REEVESD","dateModified":"2014-06-27","changeNote":"Curated to support Duke clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4566774","version":"1","preferredName":"Imaging Technique Evaluation Type","preferredDefinition":"Name of imaging procedure used in the visualization of any tissue or organ for use in screening or treatment settings.","longName":"IMG_TECH_EVAL_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"06A42434-BBF7-5020-E050-BB89AD43584A","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-30","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeNote":"2/16/15 released per 1/28 email from Dianne Reeves. jc  11/6/14 removed reference to DCP as origin; added DCI For Review CS/CSI; CDE released. jc 11/3/14 per discussion with Dianne Reeves, removed C38101 (Radiography) as qualifier for consistency with existing imaging content and to support non-Radiography imaging techniques used in RECIST measurement. jc  10/30/14 Curated to support Duke Cancer Center clinical trial. dr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4588875","version":"1","preferredName":"Isolated Chemotherapeutic Limb Perfusion Limb Infusion Procedure Completion Yes No Indicator","preferredDefinition":"Text term to signify whether an isolated limb perfusion (ILP) or isolated limb infusion (ILI) procedures was attempted as schedule or aborted prior to beginning the procedure.","longName":"ILP_ILI_PROC_COM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07BE5123-B4ED-1DB5-E050-BB89AD431F74","latestVersionIndicator":"Yes","beginDate":"2014-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-13","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Curated to support Duke Melanoma clinical trial. 11.13.2014dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4592154","version":"1","preferredName":"Isolated Chemotherapeutic Limb Perfusion Limb Infusion Procedure Incomplete Therapeutic Procedure Incomplete Reason","preferredDefinition":"Text identification of the reason an isolated limb infusion (ILI) or isolated limb perfusion (ILP) was not completed as scheduled.","longName":"ILI_ILP_INCOMPL_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07C2E3CF-979E-83DC-E050-BB89AD43091C","latestVersionIndicator":"Yes","beginDate":"2014-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-13","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Curated to support Duke Melanoma clinical trial. 11.13.2014dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4592178","version":"1","preferredName":"Isolated Chemotherapeutic Limb Perfusion Limb Infusion Procedure Incomplete Reason Decision Text","preferredDefinition":"Text description of the reason an isolated limb infusion (ILI) or isolated limb perfusion (ILP) was not completed as scheduled.","longName":"ILI_ILP_INCM_OTX_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07C32E78-1687-57DE-E050-BB89AD437A36","latestVersionIndicator":"Yes","beginDate":"2014-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-13","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Curated to support Duke Melanoma clinical trial. 11.13.2014dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4592195","version":"1","preferredName":"Isolated Chemotherapeutic Limb Perfusion Limb Infusion Anatomic Site","preferredDefinition":"Text term for the anatomic site of isolated limb infusion (ILI) or isolated limb perfusion (ILP).","longName":"ILI_ILP_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07C2B80E-EFE5-E642-E050-BB89AD4323F1","latestVersionIndicator":"Yes","beginDate":"2014-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-13","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Curated to support Duke Melanoma clinical trial. 11.13.2014dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4592233","version":"1","preferredName":"Lymphadenectomy Anatomic Site","preferredDefinition":"Text name of the surgical approach for assessing lymph involvement and lymph node dissection for disease evaluation.","longName":"LN_DISSEC_ANAT_STE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07C2B80E-F08C-E642-E050-BB89AD4323F1","latestVersionIndicator":"Yes","beginDate":"2014-11-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-13","modifiedBy":"REEVESD","dateModified":"2014-11-14","changeNote":"Curated to support Duke Melanoma clinical trial. 11.13.2014dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4718874","version":"1","preferredName":"Prior Therapy Group Assignment Identifier","preferredDefinition":"Numeric identifier for treatment modalities and systemic agent regimens for the purpose of segregating prior therapy history into the specific treatment plans.","longName":"PR_TX_GP_ASSIGN_ID","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F49E671-49D2-5BA9-E050-BB89AD436F33","latestVersionIndicator":"Yes","beginDate":"2015-02-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-17","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4733408","version":"1","preferredName":"Patient Soft Tissue Sarcoma Or Fibromatosis Diagnosis Indicator","preferredDefinition":"The response indicating whether a patient has been diagnosed with a soft tissue sarcoma or fibromatosis.","longName":"STS_FIBR_DX_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107D438A-B3C1-F4E6-E050-BB89AD4319F8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-04","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_Sarcoma Project_02.04.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4744454","version":"1","preferredName":"Radiation Therapy Post First Dose Assessment Period Type","preferredDefinition":"The response indicating the time period after the first dose of radiation therapy when an assessment occurs.","longName":"RTX_POS_DOS_PER_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"112FAAB9-4FBE-23EC-E050-BB89AD435EA4","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_Sarcoma QoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745432","version":"1","preferredName":"Radiation Therapy Planned Or Administered Course Count","preferredDefinition":"The response indicating the number of courses/rounds of radiation therapy that was either planned or administered to a patient during the course of a clinical trial.","longName":"RAD_TX_PLA_ADM_COUNT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1131FA36-FE39-DD5F-E050-BB89AD4346A6","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_Sarcoma QoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745436","version":"1","preferredName":"Radiation Therapy Planned Or Administered Dose Count","preferredDefinition":"The response indicating the number of doses of radiation that are planned for administration or that have been administered to a patient.","longName":"RTX_PLAN_ADM_DOS_COU","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11327F52-3955-DC6E-E050-BB89AD4321F4","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_SarcomaQoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745449","version":"1","preferredName":"Wound Complication Less Than Integer::30 Day Post Surgical Procedure Present Indicator","preferredDefinition":"The indicator response regarding whether there were wound complications within 30 days after surgery.","longName":"COMP_LT30_DY_SUR_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"113332B8-9366-16E0-E050-BB89AD435917","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"MORENOC","dateModified":"2017-09-25","changeNote":"DCI_SarcomaQoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745450","version":"1","preferredName":"Fracture Within Radiation Field Present Indicator","preferredDefinition":"The indicator response regarding whether a fracture occurred within the radiation field.","longName":"FRAC_WI_RX_FIELD_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"113332B8-9386-16E0-E050-BB89AD435917","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_SarcomaQoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745451","version":"1","preferredName":"Secondary Malignant Neoplasm Within Radiation Field Present Indicator","preferredDefinition":"The indicator response regarding whether a patient developed a secondary malignant neoplasm within the radiation field.","longName":"SMN_WI_RX_FIELD_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"113332B8-93A6-16E0-E050-BB89AD435917","latestVersionIndicator":"Yes","beginDate":"2015-03-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-13","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_SarcomaQoL_03.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4751031","version":"1","preferredName":"Surgical Procedure Postoperative Period Assessment Type","preferredDefinition":"The response indicating the duration of time that has occurred since a surgical procedure was performed.","longName":"SUR_PRO_POS_PD_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11FED7AC-E814-456B-E050-BB89AD4377CF","latestVersionIndicator":"Yes","beginDate":"2015-03-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-23","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753703","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to do Self-Care After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation after treatment of their satisfaction now with their ability to do self care activities such as washing and dressing after treatment.","longName":"CS_SELF_CARE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CD09-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753738","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to Get Out and About After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to get out and about after treatment.","longName":"CS_GET_OUT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120DF07A-5EA6-E759-E050-BB89AD4327D5","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753773","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to do Household Chores After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to do household choses such as cleaning and yard work after treatment.","longName":"CS_HOUSEWORK_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120DF07A-5ED0-E759-E050-BB89AD4327D5","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753775","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to Sleep After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to sleep after treatment.","longName":"CS_SLEEP_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120DF07A-5F16-E759-E050-BB89AD4327D5","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753813","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to do Recreation and Leisure Activities After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to do recreational and leisure activities such as hobbies and sports after treatment..","longName":"CS_RECREATION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CD48-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753814","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to do Social Activities After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to do social activities with family, friends, neighbors and groups after treatment.","longName":"CS_SOCIAL_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CD6E-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753815","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Ability to do Work or School Activities After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with their ability to do current work or school activities after treatment.","longName":"CS_WORKSCHOOL_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CD95-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753816","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Appearance of Arm or Leg After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with the appearance of their arm or leg after treatment.","longName":"CS_ARMLEG_APPEAR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120E4BBC-7AB4-8DF4-E050-BB89AD436B05","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753817","version":"1","preferredName":"Outcome Satisfaction Questionnaire Current Sensations in Arm or Leg After Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of their satisfaction now with the how their arm or leg feels including any sensations such as pain, numbness and tingling after treatment.","longName":"CS_ARMLEG_SENSAT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CDBC-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4753818","version":"1","preferredName":"Outcome Satisfaction Questionnaire Overall Satisfaction with Results of Treatment Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of satisfaction now with the results of their treatment.","longName":"OS_RESULTS_TRT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"120D3FFE-CDE3-6ADF-E050-BB89AD436AD3","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-25","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756464","version":"1","preferredName":"Follow-Up Outcome Expectations Questionnaire Expected Length of Time to Recover After Treatment Score 4 Point Likert Scale","preferredDefinition":"Persons' stated observation of their expected length of time to recover after treatment using a 4-point Likert scale.","longName":"EXP_LENGTH_TIME_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-7EB8-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756465","version":"1","preferredName":"Follow-Up Outcome Expectations Questionnaire Difficulty to Recover After Treatment Score 4 Point Likert Scale","preferredDefinition":"Persons' stated observation of their difficulty recovering after treatment using a 4-point Likert scale.","longName":"EXP_DIFFICULTY_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-7EDF-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756466","version":"1","preferredName":"Follow-Up Outcome Expectations Questionnaire Feelings About Ability to Deal with Treatment and Recovery Score 4 Point Likert Scale","preferredDefinition":"Persons' stated observation of their feelings about their ability to deal with treatment and recovery using a 4-point Likert scale.","longName":"EXP_TRT_RECOVERY_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-7F06-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756467","version":"1","preferredName":"Follow-Up Outcome Expectations Questionnaire Recovered Ability to do Daily Activities as Expected Score 4 Point Likert Scale","preferredDefinition":"Persons' stated observation of their recovered ability to daily activities as expected using a 4-point Likert scale.","longName":"EXP_DAILY_ACT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-7F2D-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756491","version":"1","preferredName":"EORTC/ROTG Late Radiation Morbidity Scoring Criteria Skin Grade","preferredDefinition":"The response describing the qualitative level of skin toxicity present 90 days after administration of radiation therapy.","longName":"LRMSC_SKIN_GRADE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"EORTC/RTOG Late Radiation Morbidity Scoring Criteria, Cox JD, Stetz J, Pajak TF, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12137F5E-F412-ECE9-E050-BB89AD43539B","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4756492","version":"1","preferredName":"EORTC/ROTG Late Radiation Morbidity Scoring Criteria Subcutaneous Tissue Grade","preferredDefinition":"The response describing the qualitative level of subcutaneous tissue toxicity present 90 days after administration of radiation therapy.","longName":"LRMSC_SUBCUTAN_GRADE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"EORTC/RTOG Late Radiation Morbidity Scoring Criteria, Cox JD, Stetz J, Pajak TF, 1995","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12137F5E-F439-ECE9-E050-BB89AD43539B","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"HARTLEYG","dateModified":"2015-03-26","changeNote":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4758981","version":"1","preferredName":"Supplemental FACIT Fatigue Scale Past Week How True Distressed by Trouble Falling Asleep Score 5 Point Likert Scale","preferredDefinition":"A persons' stated observation of how much in the past 7 days they are distressed by trouble falling asleep, using a five-point Likert scale.","longName":"SFFS_FALL_ASLEEP_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1223D95B-991E-2EED-E050-BB89AD436AAA","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.25.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759012","version":"1","preferredName":"Supplemental FACIT Fatigue Scale Past Week How True Distressed by Awakening in the Early Morning Score 5 Point Likert Scale","preferredDefinition":"A persons' stated observation of how much in the past 7 days they are distressed because of awakening in the early morning, using a five-point Likert scale.","longName":"SFFS_AWAKENEARLY_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12244BF3-F114-6B15-E050-BB89AD430456","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.25.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759013","version":"1","preferredName":"Supplemental FACIT Fatigue Scale Past Week How True Distressed by Sleep that is Restless and Disturbed Score 5 Point Likert Scale","preferredDefinition":"A persons' stated observation of how much in the past 7 days they have been distressed because they have sleep that is restless and disturbed, using a five-point Likert scale.","longName":"SFFS_SLEEP_DIST_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12244BF3-F13B-6B15-E050-BB89AD430456","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.25.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759195","version":"1","preferredName":"Edmonton Symptom Assessment System-Sarcoma Modified Patient Identifier Number","preferredDefinition":"A unique identifier used for participation in the Edmonton Symptom Assessment System-Sarcoma Modified questionnaire.","longName":"ESASSM_PT_ID_NUMBER","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1224C087-72B8-2257-E050-BB89AD43147B","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759471","version":"1","preferredName":"Edmonton Symptom Assessment System-Sarcoma Modified  Current Assessment Best Ability to Move Normally To Worst Possible Ability to Move Normally Score 11 Point Scale","preferredDefinition":"A persons' stated observation of their current ability to move normally using a 11 point Likert scale.","longName":"ESASSM_MOVENORMAL_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12267EC7-B4EE-336E-E050-BB89AD432C68","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759472","version":"1","preferredName":"Edmonton Symptom Assessment System-Sarcoma Modified Current Assessment Biggest Problem Completely Resolved To Biggest Problem Worse than Ever Score 11 Point Scale","preferredDefinition":"A persons' stated observation of their current biggest problem using a 11 point Likert scale.","longName":"ESASSM_BIGPROBLEM_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12267EC7-B515-336E-E050-BB89AD432C68","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759473","version":"1","preferredName":"Edmonton Symptom Assessment System-Sarcoma Modified Biggest Problem Descriptive Text","preferredDefinition":"A persons' description of their biggest problem or symptom.","longName":"ESASSM_BIG_PROB_TEXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12267EC7-B53C-336E-E050-BB89AD432C68","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759501","version":"1","preferredName":"Stern's Rating Scale for Edema Score 5 Point Scale","preferredDefinition":"A physician's subjective rated measure of edema using a 5 point Likert scale.","longName":"STERN_EDEMA_5_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Stern TN. Cinical Examination, 1964","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1226E673-5110-B0C7-E050-BB89AD431A66","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.25.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4759511","version":"1","preferredName":"Follow-Up Embodiment/Outcomes Questionnaire Feelings About Arm or Leg Most of the Time Status 4 Point Scale","preferredDefinition":"Persons' stated observation of their feelings most of the time about their arm or leg, using a 4 point scale.","longName":"FUEO_FEEL_ARMLEG_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1227BF4F-6831-1217-E050-BB89AD430EF5","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.25.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761345","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Put on a Pair of Pants Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on a pair of pants, using a 5 point Likert scale.","longName":"TESSUE_PANTS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C897-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761346","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Tie Shoe Laces Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week tying shoe laces, using a 5 point Likert scale.","longName":"TESSUE_LACES_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C8BE-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761347","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Put on Socks or Stockings Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on socks or stockings, using a 5 point Likert scale.","longName":"TESSUE_SOCKS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C8E5-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761348","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Shower Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week showering, using a 5 point Likert scale.","longName":"TESSUE_SHOWERING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C90C-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761349","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Dress My Arms and Upper Body Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week dressing their arms and upper body, using a 5 point Likert scale.","longName":"TESSUE_DRESSING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C933-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761350","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Button a Shirt Difficulty Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week buttoning a shirt, using a 5 point Likert scale.","longName":"TESSUE_BUTTONING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C95A-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761351","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Tie a Tie or Bow at the Neck of a Blouse Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week tying a tie or bow at the neck of a blouse, using a 5 point Likert scale.","longName":"TESSUE_TYING_TIE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C981-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761352","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Put on Make-Up or Shave Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on make-up or shaving, using a 5 point Likert scale.","longName":"TESSUE_SHAVING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C9A8-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761353","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Brush Your Teeth Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week brushing their teeth, using a 5 point Likert scale.","longName":"TESSUE_TEETH_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C9CF-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761371","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Brush Your Hair Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week brushing your hair, using a 5 point Likert scale.","longName":"TESSUE_HAIR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-C9F6-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761372","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Do Light Household Chores Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week doing light household chores, using a 5 point Likert scale.","longName":"TESSUE_LTCHORE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CA1D-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761373","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Garden or Do Yard Work Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week gardening or doing yard work, using a 5 point Likert scale.","longName":"TESSUE_GARDENING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CA44-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761374","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Prepare and Serve Meals Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week preparing and serving meals, using a 5 point Likert scale.","longName":"TESSUE_PREPMEALS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CA6B-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761375","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Cut Food While Eating Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week cutting food while eating, using a 5 point Likert scale.","longName":"TESSUE_CUTFOOD_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CA92-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761376","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Drink From a Glass Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week drinking from a glass, using a 5 point Likert scale.","longName":"TESSUE_DRINKING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CAB9-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761377","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Do Heavy Household Chores Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week performing heavy household chores, using a 5 point Likert scale.","longName":"TESSUE_HVYCHORES_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CAE0-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761378","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Go Shopping Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week going shopping, using a 5 point Likert scale.","longName":"TESSUE_SHOPPING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CB07-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761379","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Give or Receive Change Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week giving or receiving change such as coins or bills, using a 5 point Likert scale.","longName":"TESSUE_CHANGE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CB2E-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761380","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Carry a Shopping Bag or Briefcase Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week carrying a shopping bag or briefcase, using a 5 point Likert scale.","longName":"TESSUE_CARRYING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CB55-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761381","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Lift a Box to an Overhead Shelf Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week lifting a box to an overhead shelf, using a 5 point Likert scale.","longName":"TESSUE_LIFTBOX_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CB7C-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761382","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Turn a Key in a Lock Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week turning a key in a lock, using a 5 point Likert scale.","longName":"TESSUE_TURNKEY_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CBA3-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761391","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Push or Pull Open a Door Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week pushing or pulling open a door, using a 5 point Likert scale.","longName":"TESSUE_OPENDOOR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CBCA-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761392","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Write Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week writing, using a 5 point Likert scale.","longName":"TESSUE_WRITING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CBF1-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761393","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Pick Up Small Items Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week picking up small items, using a 5 point Likert scale.","longName":"TESSUE_PICKUP_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CC18-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761394","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Complete My Usual Duties at Work Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week completing their usual duties at work including a job outside the home or as a homemaker, using a 5 point Likert scale.","longName":"TESSUE_USUALWORK_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CC3F-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761395","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Ability to Work My Usual Number of Hours Difficulty Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week working their usual number of hours including both a job outside the home and as a homemaker, using a 5 point Likert scale.","longName":"TESSUE_USUALHOUR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CC66-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761396","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Participate in My Usual Leisure Activities Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week participating in my usual leisure activities, using a 5 point Likert scale.","longName":"TESSUE_LEISURE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CC8D-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761397","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Socialize with Friends and Family Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week socializing with friends and family, using a 5 point Likert scale.","longName":"TESSUE_SOCIALIZE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CCB4-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761398","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Participate in My Usual Sporting Activities Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week participating in their usual sporting activities, using a 5 point Likert scale.","longName":"TESSUE_SPORTS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CCDB-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761399","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Difficulty Ability to Perform all the Activities in Which I Participate in Daily Life Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week performing all the activities in which they participate in daily life, using a 5 point Likert scale.","longName":"TESSUE_DAILYLIFE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CD02-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761411","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Past Week Rating Myself Disabled Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation rating themselves disabled, using a 5 point Likert scale.","longName":"TESSUE_DISABLED_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CD2C-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4761412","version":"1","preferredName":"Toronto Extremity Salvage Score, Upper Extremity Activity Descriptive Text","preferredDefinition":"Persons' comments regarding any activities that they find difficult to perform or on any other difficulties they experienced due to the problem they currently have in their arm that they feel are important and have not been asked about in this questionnaire.","longName":"TESSUE_ACTIVITY_TEXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1239A276-CD53-2454-E050-BB89AD4307B0","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-26","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763591","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Put on a Pair of Pants Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on a pair of pants, using a 5 point Likert scale.","longName":"TESSLE_PANTS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124DE556-DF3A-693D-E050-BB89AD435E50","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763592","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Put on Shoes Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on shoes, using a 5 point Likert scale.","longName":"TESSLE_SHOES_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C5B3-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763596","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Put on Socks or Stockings Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week putting on socks or stockings, using a 5 point Likert scale.","longName":"TESSLE_SOCKS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C5DD-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763611","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Shower Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week showering, using a 5 point Likert scale.","longName":"TESSLE_SHOWERING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124DE556-DFA5-693D-E050-BB89AD435E50","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763612","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Do Light Household Chores Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week doing light household chores such as tidying and dusting, using a 5 point Likert scale.","longName":"TESSLE_LTCHORES_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C605-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763613","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Garden or Do Yard Work Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week gardening and doing yard work, using a 5 point Likert scale.","longName":"TESSLE_GARDENING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C631-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763614","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Prepare and Serve Meals Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week preparing and serving meals, using a 5 point Likert scale.","longName":"TESSLE_SERVEMEAL_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C658-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763615","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Go Shopping Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week going shopping, using a 5 point Likert scale.","longName":"TESSLE_SHOPPING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124EA2FD-C67F-D4FB-E050-BB89AD432647","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763616","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Do Heavy Household Chores Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week doing heavy household chores such as vacuuming and moving furniture, using a 5 point Likert scale.","longName":"TESSLE_HVYCHORES_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"124ED9B2-6DD1-B10A-E050-BB89AD436D56","latestVersionIndicator":"Yes","beginDate":"2015-03-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-27","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.27.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763851","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Get In and Out of the Bath Tub Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week getting in and out of the bath tub, using a 5 point Likert scale.","longName":"TESSLE_BATHTUB_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8EAE-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763852","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Get Out of Bed Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week getting out of bed, using a 5 point Likert scale.","longName":"TESSLE_OUTOFBED_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8ED5-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763853","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Rise from a Chair Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week rising from a chair, using a 5 point Likert scale.","longName":"TESSLE_RISECHAIR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8EFF-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763871","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Kneel 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week kneeling, using a 5 point Likert scale.","longName":"TESSLE_KNEELING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8F39-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763891","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Bend to Pick Something Up Off the Floor Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week bending to pick something up off the floor, using a 5 point Likert scale.","longName":"TESSLE_BENDING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8F60-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763892","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Walk Upstairs Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week walking upstairs, using a 5 point Likert scale.","longName":"TESSLE_WALKUP_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8F87-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763893","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Walk Downstairs Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week walking downstairs, using a 5 point Likert scale.","longName":"TESSLE_WALKDOWN_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8FAE-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763894","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Drive Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week driving, using a 5 point Likert scale.","longName":"TESSLE_DRIVING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8FD5-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763895","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Ability to Walk Within the House Score Difficulty Ability to Walk Within the House 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week walking within the house, using a 5 point Likert scale.","longName":"TESSLE_WALKHOUSE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1284C565-8FFC-68EC-E050-BB89AD437F72","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763896","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Walk Outdoors Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week walking outdoors, using a 5 point Likert scale.","longName":"TESSLE_WALKOUT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128526DF-DDFB-1A42-E050-BB89AD4377A8","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763897","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Sit Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week sitting, using a 5 point Likert scale.","longName":"TESSLE_SITTING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128526DF-DE22-1A42-E050-BB89AD4377A8","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763898","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Walk Up or Down Hills or a Ramp Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week walking up or down hills or a ramp, using a 5 point Likert scale.","longName":"TESSLE_WALKHILLS_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A819-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-04-01","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763899","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Stand Upright Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week standing upright, using a 5 point Likert scale.","longName":"TESSLE_STANDUP_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A840-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763900","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Get Up from Kneeling Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week getting up from kneeling, using a 5 point Likert scale.","longName":"TESSLE_UPKNEEL_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A867-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763901","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Get In and Out of a Car Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week getting in and out of a car, using a 5 point Likert scale.","longName":"TESSLE_INOUTCAR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A88E-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763902","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Participate in Sexual Activities Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week participating in sexual activities, using a 5 point Likert scale.","longName":"TESSLE_SEXUALACT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A8B5-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763903","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Complete My Usual Duties at Work Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week completing their usual duties at work including both a job outside the home and as a homemaker, using a 5 point Likert scale.","longName":"TESSLE_USUALWORK_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A8DC-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763904","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Work My Usual Number of Hours Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week working their usual number of hours including both a job outside the home and as a homemaker, using a 5 point Likert scale.","longName":"TESSLE_USUALHOUR_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A903-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763905","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Participate in My Usual Leisure Activities Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week participating in their usual activities, using a 5 point Likert scale.","longName":"TESSLE_LEISURE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A92A-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763906","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Socialize with Friends and Family Score 5 Point Likert Scale","preferredDefinition":"Person's stated observation of the difficulty in the past week socializing with friends and family, using a 5 point Likert scale.","longName":"TESSLE_SOCIALIZE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A951-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763947","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Participate in My Usual Sporting Activities Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week participating in their usual sporting activities, using a 5 point Likert scale.","longName":"TESSLE_SPORTING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"128534AD-A98B-4140-E050-BB89AD436DAC","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763948","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Perform all the Activities in Which I Participate in Daily Life Score Toronto Extremity Salvage Score Difficulty 5 Point Likert Scale","preferredDefinition":"Persons' stated observation of the difficulty in the past week performing all the activities in which they participate in daily life, using a 5 point Likert scale.","longName":"TESSLE_DAILYLIFE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12857E2B-464C-0CE9-E050-BB89AD4357D9","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763951","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Past Week Rating Myself Disabled Score 5 Point Likert Scale","preferredDefinition":"Persons' stated observation rating themselves disabled, using a 5 point Likert scale.","longName":"TESSLE_RATING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12857E2B-468E-0CE9-E050-BB89AD4357D9","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4763957","version":"1","preferredName":"Toronto Extremity Salvage Score, Lower Extremity Activity Description Text","preferredDefinition":"Persons' comments regarding any activities that they find difficult to perform or on any other difficulties they experienced due to the problem they currently have in their leg that they feel are important and have not been asked about in this questionnaire.","longName":"TESSLE_ACTIVITY_TEXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Toronto Extremity Salvage Score (TESS); 1996","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12857E2B-46B4-0CE9-E050-BB89AD4357D9","latestVersionIndicator":"Yes","beginDate":"2015-03-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-30","modifiedBy":"HARTLEYG","dateModified":"2015-03-31","changeNote":"DCI_Sarcoma QoL Project_03.30.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767351","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Complete Indicator","preferredDefinition":"The indicator response regarding whether the Musculoskeletal Tumor Society Rating Scale measure has been completed.","longName":"MSTS_COMP_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129EA6BC-6D4F-3B0F-E050-BB89AD4318CE","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767354","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Calculated Extremity Score","preferredDefinition":"The numerical value representing the calculated physical functioning score of an individual with musculoskeletal cancer.","longName":"MSTS_CALC_EXT_SCORE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F3246-4BD3-12AD-E050-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767355","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Pain Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity pain, using a six-point Likert scale.","longName":"MSTS_UP_PAIN_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F3246-4BFA-12AD-E050-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767356","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Functional Activity Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity functional activity, using a six-point Likert scale.","longName":"MSTS_UP_FUNCTION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F3246-4C21-12AD-E050-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767357","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Emotional Acceptance Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity emotional acceptance, using a six-point Likert scale.","longName":"MSTS_UP_EMOTION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F3246-4C48-12AD-E050-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767358","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Hand Positioning Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity hand positioning, using a six-point Likert scale.","longName":"MSTS_UP_HAND_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F3246-4C6F-12AD-E050-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767359","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Manual Dexterity Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity manual dexterity, using a six-point Likert scale.","longName":"MSTS_UP_DEXTERITY_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B762-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767360","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Upper Extremity Lifting Ability Score 6 Point Scale","preferredDefinition":"Person's stated observation of upper extremity lifting ability, using a six-point Likert scale.","longName":"MSTS_UP_LIFTING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B789-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767361","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Pain Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity pain, using a six-point Likert scale.","longName":"MSTS_LOW_PAIN_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B7B0-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767362","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Functional Activity Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity functional activity, using a six-point Likert scale.","longName":"MSTS_LOWFUNCTION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B7D7-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767363","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Emotional Acceptance Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity emotional acceptance, using a six-point Likert scale.","longName":"MSTS_LOW_EMOTION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B7FE-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767364","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Supports Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity supports, using a six-point Likert scale.","longName":"MSTS_LOW_SUPPORT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B825-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767365","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Walking Ability Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity walking ability, using a six-point Likert scale.","longName":"MSTS_LOW_WALKING_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B84C-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4767366","version":"1","preferredName":"Musculoskeletal Tumor Society Rating Scale Lower Extremity Gait Score 6 Point Scale","preferredDefinition":"Person's stated observation of lower extremity gait, using a six-point Likert scale.","longName":"MSTS_LOW_GAIT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Musculoskeletal Tumor Society Rating Scale; 1993","workflowStatus":"RELEASED","registrationStatus":"Application","id":"129F56A9-B873-DCC1-E050-BB89AD434331","latestVersionIndicator":"Yes","beginDate":"2015-03-31","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-31","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_03.31.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4769391","version":"1","preferredName":"Therapeutic Procedure Limb Recovery Expected Duration Code","preferredDefinition":"Coded response indicating a persons' stated expectation of the length of time required to recover from their limb treatment.","longName":"LMB_TX_RCV_EX_DUR_CD","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12AE43F1-700A-7314-E050-BB89AD437A0A","latestVersionIndicator":"Yes","beginDate":"2015-04-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-01","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_04.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4769398","version":"1","preferredName":"Therapy Complication Expected Coded Indicator","preferredDefinition":"A coded response indicating whether a person expects to experience complications from their limb treatment.","longName":"TX_COMP_EXP_IND_CD","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12AE43F1-704D-7314-E050-BB89AD437A0A","latestVersionIndicator":"Yes","beginDate":"2015-04-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-01","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_04.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4769435","version":"1","preferredName":"Initial Outcome Expectations Questionnaire Perform Daily Activities Post Limb Therapeutic Procedure Recovery Score  4 Point Scale","preferredDefinition":"Persons' stated expectation of the difficulty of daily activities once they have recovered from their limb treatment.","longName":"IOE_DAILY_ACT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12B06A28-4B10-123E-E050-BB89AD43630F","latestVersionIndicator":"Yes","beginDate":"2015-04-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-01","modifiedBy":"HARTLEYG","dateModified":"2015-04-06","changeNote":"DCI_Sarcoma QoL Project_04.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788411","version":"1","preferredName":"Disease Involved Location Anatomic Site Name","preferredDefinition":"The response indicating the anatomic site location name(s) that are involved in disease.","longName":"DS_INV_LOC_ASITE_NAM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-48B3-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"HARTLEYG","dateModified":"2015-04-13","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788412","version":"1","preferredName":"Disease Involved Location Indicator","preferredDefinition":"The indicator response regarding whether an anatomic site is involved in disease.","longName":"DS_INV_LOC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-48D4-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"HARTLEYG","dateModified":"2015-04-13","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788413","version":"1","preferredName":"Bone Involved Anatomic Site Specify","preferredDefinition":"The text response indicating the specific bone(s) involved in disease.","longName":"BONE_INV_SITE_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-4901-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"KUMMEROA","dateModified":"2022-06-28","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788414","version":"1","preferredName":"Patient Current Pain Finding Result Status","preferredDefinition":"The response indicating the status of pain an individual is currently experiencing as compared to a previous examination or evaluation.","longName":"PT_PAIN_RES_STATUS","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-4922-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"HARTLEYG","dateModified":"2015-04-13","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788415","version":"2","preferredName":"Soft Tissue Involved Mass Extent Name","preferredDefinition":"The response indicating the extent of disease involvement in soft tissue.","longName":"SFT_TIS_INV_NAME","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D4C01F2-2C50-FF21-E050-BB89AD437818","latestVersionIndicator":"Yes","beginDate":"2015-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-14","modifiedBy":"COOPERM","dateModified":"2015-08-14","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd Created new version to extend VD max length and PV list per COG request. mc 8/14/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788416","version":"1","preferredName":"Soft Tissue Involved Anatomic Site Other Specify","preferredDefinition":"The text describing other soft tissue sites of disease involvement.","longName":"SOF_TIS_INV_SIT_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-4972-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"COOPERM","dateModified":"2018-08-20","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788417","version":"1","preferredName":"Bone Involved Anatomic Site Other Specify","preferredDefinition":"The text response describing the other bone site involved in disease.","longName":"BON_INV_SITE_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-4993-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"HARTLEYG","dateModified":"2015-04-13","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4788418","version":"1","preferredName":"Current Disease Metastasis Indicator","preferredDefinition":"The indicator response regarding whether metastasis has occurred.","longName":"DIS_MET_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1366F0F1-49CE-BB54-E050-BB89AD43464C","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-10","modifiedBy":"HARTLEYG","dateModified":"2015-04-13","changeNote":"DCI_Sarcoma QoL Project_04.10.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4824544","version":"1","preferredName":"Sarcoma World Health Organization Classification Category","preferredDefinition":"Text term that represents the World Health Organization (WHO) classification for the patient's Sarcoma diagnosis, usually an aggressive malignant neoplasm of soft tissue or bone.","longName":"SAR_WHO_CLAS_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"WHO:World Health Organization","workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE371D-3449-2E29-E050-BB89AD430406","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"HARTLEYG","dateModified":"2015-05-15","changeNote":"Sarcoma_DCI_05.12.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843811","version":"1","preferredName":"Walking Assistive Device Chosen Indicator","preferredDefinition":"The response that indicates whether a person has chosen to use a walking aid such as a cane, walker, crutches, etc.","longName":"WALK_AST_DEVICE_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-99BD-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843812","version":"1","preferredName":"Walking Assistive Device Chosen Type Text","preferredDefinition":"The text response that indicates the type of device used by the person to aid in walking.","longName":"WALK_AST_DEVICE_TEXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-99DE-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.1.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843813","version":"1","preferredName":"Muscle Cross-section Area Assessment Indicator","preferredDefinition":"The response that indicates whether a cross-sectional area of muscle has been measured.","longName":"MUSCLE_XSEC_AREA_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C85A0-171A-19F5-E050-BB89AD433AB0","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843816","version":"1","preferredName":"Muscle Cross-section Area Assessment Anatomic Site","preferredDefinition":"The text response that indicates the anatomic site where the muscle was selected for cross-sectional analysis.","longName":"MUSC_XSEC_AREA_ASITE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C85A0-1783-19F5-E050-BB89AD433AB0","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843838","version":"1","preferredName":"Muscle Mean Cross-section Area Value","preferredDefinition":"The numerical value that represents the mean muscle area measured in the cross-sectional analysis.","longName":"MUS_MN_XSEC_AREA_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C85A0-17A4-19F5-E050-BB89AD433AB0","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843844","version":"1","preferredName":"Timed Up and Go Functional Test Performed Duration Second Value","preferredDefinition":"The numerical value that indicates the number of seconds that were required to complete the Timed Up and Go Functional Measure assessment.","longName":"UP_GO_DUR_SEC_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-99FF-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843851","version":"1","preferredName":"6 Minute Walk Functional Test Resting Period Frequency Count","preferredDefinition":"The numerical response that indicates the number of rest breaks that a person required during the course of the Six-Minute Walk Test.","longName":"SIXMIN_REST_FREQ_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-9A31-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843852","version":"1","preferredName":"Person Physical Restriction Text","preferredDefinition":"The text response that indicates a person's physical restrictions or injuries that would impede exercise.","longName":"PHYS_RESTRICT_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-9A52-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843871","version":"1","preferredName":"Muscle Physical Strength And Endurance Assessment Exercise Timepoint Type","preferredDefinition":"The response that indicates the timepoint that an assessment was performed during the exercise testing.","longName":"EXERCISE_TIMEPT_TYPE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-9A73-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843893","version":"1","preferredName":"Physical Exercise Performance Name","preferredDefinition":"The response that names of a type of physical exercise.","longName":"PHYS_EXERCISE_NAME","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177C5FB9-9AAB-03B2-E050-BB89AD434BF4","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843901","version":"1","preferredName":"Exercise Lifting Weight Value","preferredDefinition":"The numeric answer that represents the amount of weight a person was capable of lifting/pushing/pulling as part of a specific exercise.","longName":"EXERCISE_LIFT_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177D51D9-1CFB-7367-E050-BB89AD433961","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4843911","version":"1","preferredName":"Exercise Repetition Number Count","preferredDefinition":"The numeric value that indicates the number of repetitions of an individual exercise that were completed within a specific time period.","longName":"EXERCISE_REP_NUM_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177D51D9-1D22-7367-E050-BB89AD433961","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844012","version":"1","preferredName":"Blood Pressure Measurement Anatomic Site","preferredDefinition":"The response that indicates the anatomic site where blood pressure is measured on a person.","longName":"BP_MEAS_ANAT_SITE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177D51D9-1F02-7367-E050-BB89AD433961","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844027","version":"1","preferredName":"Cardiopulmonary Exercise Testing Stage Assessment Category","preferredDefinition":"The response that indicates the stage of the of testing for a cardiopulmonary exercise assessment.","longName":"CARDIO_EXERC_STG_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177E26C8-360F-5FC7-E050-BB89AD437FF7","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844031","version":"1","preferredName":"Cardiopulmonary Exercise Testing Assessment Timepoint Type","preferredDefinition":"The response that indicates the timepoint the measurements were made during the cardiopulmonary exercise testing.","longName":"CARDIO_EXER_TMPT_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177D51D9-1F2F-7367-E050-BB89AD433961","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844093","version":"2","preferredName":"Surface Angle Increase Percentage Value","preferredDefinition":"The numerical response indicating the percent of incline for a surface as measured from a horizontal plane.","longName":"SURF_ANG_INC_PER_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3BE2-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 with increased overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844095","version":"1","preferredName":"Electrocardiogram Finding Arrhythmia Other Specify","preferredDefinition":"The text response that indicates a type of arrhythmia that was identified on an EKG that has not otherwise been specified.","longName":"EKG_ARRHYTHMIA_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177E7ABF-97D4-E184-E050-BB89AD430503","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844116","version":"1","preferredName":"Cardiopulmonary Exercise Testing Assessment Restriction Reason","preferredDefinition":"The response that indicates the reason that a test was restricted or terminated.","longName":"CARDIO_RESTRICT_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177E7ABF-980D-E184-E050-BB89AD430503","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844154","version":"2","preferredName":"Oxygen Peak Uptake Relative Value Rate","preferredDefinition":"The numeric response that indicates the maximum rate of oxygen consumption as measured during incremental exercise as measured in ml/kg/min.","longName":"OXY_PK_UP_REL_VAL_RT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3C3D-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.01.15_ghd.  v2.0 replaces v1.0 with increased overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844171","version":"1","preferredName":"Dual X-ray Absorptiometry Assessment Performed Anatomic Site Type","preferredDefinition":"The response that indicates the anatomic site that is being evaluated using dual x-ray absorptiometry.","longName":"2414817v1.0:4842752v1.0","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"177E7ABF-98C0-E184-E050-BB89AD430503","latestVersionIndicator":"Yes","beginDate":"2015-06-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-01","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.01.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844896","version":"1","preferredName":"Single Chair Standing Safety Indicator","preferredDefinition":"The response that indicates whether it is safe for the person to stand during the single chair stand exercise.","longName":"CHAIR_STAND_SAFE_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1791FB67-D07B-F0D9-E050-BB89AD430AA6","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-02","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.02.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844897","version":"1","preferredName":"Repeat Chair Standing Duration Score","preferredDefinition":"The response that indicates the score assigned to the duration for completion of the repeated chair stands exercise.","longName":"RP_CHAIR_STD_DUR_SCO","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1791FB67-D09C-F0D9-E050-BB89AD430AA6","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-02","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.02.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844898","version":"1","preferredName":"Chair Standing Integer::30 Second Attempt Count","preferredDefinition":"The numeric response that indicates the number of chair stands an individual was able to complete during 30 seconds of the repeated chair stand exercise.","longName":"CHR_STAND_30SEC_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1791FB67-D0CC-F0D9-E050-BB89AD430AA6","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-02","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.02.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844950","version":"1","preferredName":"One Repetition Maximum Calculated Weight Value","preferredDefinition":"The numeric response that represents the calculated maximum amount of force that can be generated in one maximal muscle contraction or the maximum amount of weight that can be cycled through one repetition of a particular movement or exercise measured in pounds.","longName":"ONEREPMX_CALC_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1791FB67-D1DE-F0D9-E050-BB89AD430AA6","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-02","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.02.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845009","version":"1","preferredName":"Resting ST Segment Deviation Aggregate Measurement Length Value","preferredDefinition":"The numerical value that represents the length of the deviation of the ST segment on an EKG measured in millimeters while patient is in a supine position.","longName":"RESTST_DEVIA_LEN_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1791FB67-D22F-F0D9-E050-BB89AD430AA6","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-02","modifiedBy":"HARTLEYG","dateModified":"2015-07-29","changeNote":"ExercisePhys_DCI_06.02.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845051","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Bone Mineral Density Measurement Weight Value","preferredDefinition":"The numeric response that represents the bone mineral content using a Dual X-ray Absorptometry measured in grams.","longName":"DXA_BMC_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3C6D-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 with increase in overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845071","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Total Body Fat Measurement Weight Value","preferredDefinition":"The numeric response that represents the total body fat content using a Dual X-ray Absorptometry measured in grams.","longName":"DXA_FAT_MSMRT_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3B23-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 with increase in overall field length and decimal places. 1.15.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845102","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Lean Body Mass Measurement Weight Value","preferredDefinition":"The numeric response that represents the lean body mass content using a Dual X-ray Absorptometry measured in grams.","longName":"DXA_LEAN_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3B53-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 with increased overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845120","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Bone Mineral Density And Lean Body Mass Measurement Weight Value","preferredDefinition":"The numeric response that represents the bone mineral content and lean muscle weight using a Dual X-ray Absorptometry measured in grams.","longName":"DXA_BMC_LEAN_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3B82-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"HARTLEYG","dateModified":"2018-11-08","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 to increase overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845128","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Total Body Mass Measurement Weight Value","preferredDefinition":"The numeric response that represents the total body mass content using a Dual X-ray Absorptometry measured in grams.","longName":"DXA_T_BODY_MS_WT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3BB2-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 with increased overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845129","version":"2","preferredName":"Bioelectrical Impedance Dual X-ray Absorptometry Total Body Fat Measurement Percentage Value","preferredDefinition":"The numeric response that represents the percent of total body fat content calculated using measurements using a Dual X-ray Absorptometry.","longName":"DXA_FAT_PERC_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3AF3-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.02.15_ghd. v2.0 replaces v1.0 of CDE with increased field length and decimal places. 1.15.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888031","version":"1","preferredName":"Injection Site Radioactivity Gamma Camera Measurement Counts per Minute Value","preferredDefinition":"Numeric value of the baseline or background radioactivity in an imaging room measured using a gamma camera.","longName":"INJ_SIT_RDCT_CPM_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D8D9-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888032","version":"1","preferredName":"Injection Site Radioactivity Gamma Camera Measurement Counts per Minute Value","preferredDefinition":"Numeric value of the radioactivity at an injection site measured as counts per minute (CPM) using a gamma camera.","longName":"INJ_STE_RDCY_CPM_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D8F9-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888033","version":"1","preferredName":"Injection Site Dendritic Cell Measurement Percent Value","preferredDefinition":"Percentage value of dendritic cells at an injection site.","longName":"INJ_STE_DEND_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D918-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888034","version":"1","preferredName":"Right Lymph Node Radioactivity Gamma Camera Measurement Counts per Minute Value","preferredDefinition":"Numeric value of the radioactivity at a lymph node right of an injection site and measured as counts per minute (CPM) using a gamma camera.","longName":"R_LN_RDCY_CPM_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D93A-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888035","version":"1","preferredName":"Right Lymph Nodes Vs Initial Injection Dendritic Cell Measurement Percent Value","preferredDefinition":"Percentage value of dendritic cells in lymph nodes right of the initial injection as compared to the dendritic cell count at the initial injection site.","longName":"RLN_STE_DEND_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D959-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888036","version":"1","preferredName":"Left Lymph Node Radioactivity Gamma Camera Measurement Counts per Minute Value","preferredDefinition":"Numeric value of the radioactivity at a lymph node left of an injection site and measured as counts per minute (CPM) using a gamma camera.","longName":"L_LN_RDCY_CPM_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D978-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888037","version":"1","preferredName":"Left Lymph Nodes Vs Initial Injection Dendritic Cell Measurement Percentage Value","preferredDefinition":"Percentage value of dendritic cells in lymph nodes left of the initial injection as compared to the dendritic cell count at the initial injection site.","longName":"LLN_STE_DEND_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1959A738-D997-F251-E050-BB89AD433643","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"REEVESD","dateModified":"2015-06-25","changeNote":"Curated to support Gamma Camera CRF from Duke clinical trial in Rave.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888611","version":"1","preferredName":"Repeat Chair Standing Duration Time Second Value","preferredDefinition":"The numerical response that indicates the number of seconds required to complete the Repeated Chair Stand (5X) exercise.","longName":"RCS_DUR_TIME_SEC_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1973D151-85CC-1608-E050-BB89AD430A8C","latestVersionIndicator":"Yes","beginDate":"2015-06-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-26","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_06.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888615","version":"1","preferredName":"Muscle 70 Percent One Repetition Maximum Endurance Number Count","preferredDefinition":"The numerical response that indicates the number of repetitions used to define muscle endurance measured at 70% of 1Rm.","longName":"MUS_79PCT_1RM_NUM_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1973D151-8615-1608-E050-BB89AD430A8C","latestVersionIndicator":"Yes","beginDate":"2015-06-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-06-26","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_06.26.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888660","version":"2","preferredName":"Pre-Calibration Oxygen Measurement Percentage Value","preferredDefinition":"The numerical response indicating the percent of oxygen measured in a specimen/air sample prior to calibration of the equipment.","longName":"PRE_CALIB_O2_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3CFC-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.26.15_ghd. v2.0 replaces v1.0 with increased overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888661","version":"2","preferredName":"Pre-Calibration Carbon Dioxide Measurement Percentage Value","preferredDefinition":"The numerical response indicating the percent of carbon dioxide measured in a specimen/air sample prior to calibration of the equipment.","longName":"PRE_CALIB_CO2_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3C9C-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.26.15_ghd. v2.0 replaces v1.0 to increase overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888662","version":"2","preferredName":"Post Calibration Oxygen Measurement Percentage Value","preferredDefinition":"The numerical response indicating the percent of oxygen measured in a specimen/air sample after calibration of the equipment.","longName":"POST_CALIB_O2_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3D2D-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.26.15_ghd. v2.0 replaces v1.0 with increase in overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888663","version":"2","preferredName":"Post Calibration Carbon Dioxide Measurement Percentage Value","preferredDefinition":"The numerical response indicating the percent of carbon dioxide measured in a specimen/air sample after calibration of the equipment.","longName":"POST_CALIB_CO2_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3CCD-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_06.26.15_ghd. v2.0 replaces v1.0 to increase overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4920211","version":"1","preferredName":"Walking Lap Completed Count","preferredDefinition":"The numeric response indicating the number of laps completed around a circuit or course by walking.","longName":"WLK_LAP_CMP_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B920451-751C-12F3-E050-BB89AD432CF5","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-07-23","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys__DCI_07.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4920251","version":"1","preferredName":"6 Minute Walk Functional Test Resting Period Duration Minute Count","preferredDefinition":"The numeric response indicating the number of minutes a participant was not walking (resting) during a 6 Minute-Walk test.","longName":"6MW_REST_DUR_MIN_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B920451-7568-12F3-E050-BB89AD432CF5","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-07-23","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_07.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4920271","version":"1","preferredName":"6 Minute Walk Functional Test Resting Period Duration Second Count","preferredDefinition":"The numeric response indicating the number of seconds a participant was not walking (resting) during a 6 Minute-Walk test.","longName":"6MW_REST_DUR_SEC_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B920451-7589-12F3-E050-BB89AD432CF5","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-07-23","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_07.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4925334","version":"1","preferredName":"Cardiopulmonary Exercise Testing Stop Reason Other Specify","preferredDefinition":"The response that describes the reason the cardiopulmonary exercise test was terminated that had not been previously listed as a selection.","longName":"EXERC_STOP_RSN_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C0A0622-0BDE-686B-E050-BB89AD433310","latestVersionIndicator":"Yes","beginDate":"2015-07-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-07-29","modifiedBy":"HARTLEYG","dateModified":"2015-07-31","changeNote":"ExercisePhys_DCI_07.28.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928289","version":"1","preferredName":"Borg Scale Rating of Perceived Exertion Questionnaire Rating of Perceived Exertion Score 15 Point Scale","preferredDefinition":"A person's stated observation of the rate of their perceived exertion, using a 15 point Likert scale.","longName":"BORG_RPE_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C7F942E-A86E-B13F-E050-BB89AD436560","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2015-08-05","changeNote":"ExercisePhys_DCI_08.04.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928311","version":"1","preferredName":"Borg Category-Ratio 10 Scale Questionnaire Dyspnea Right Now Score 11 Point Scale","preferredDefinition":"Person's stated observation of dyspnea right now using a 11 point Likert scale.","longName":"BORG_CR10_DYSPNEA_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C7F942E-A88E-B13F-E050-BB89AD436560","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-04","modifiedBy":"TITARENKOI","dateModified":"2020-05-28","changeNote":"ExercisePhys_DCI_08.04.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928479","version":"1","preferredName":"Borg Category-Ratio 10 Scale Questionnaire Leg Fatigue Right Now Score 11 Point Scale","preferredDefinition":"Person's state observation of their leg fatigue right now, using a 11 point Likert scale.","longName":"BORG_CR10_LEGFAT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E3C7-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-04","modifiedBy":"HARTLEYG","dateModified":"2015-08-05","changeNote":"ExercisePhys_DCI_08.04.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928872","version":"1","preferredName":"Duke Psychosocial Questionnaire How Motivated to Exercise 30 Minutes per Day for 5 Days a Week Over Next 24 Weeks Score 7 Point Visual Analogue Scale","preferredDefinition":"A person's observation of how motivated they are to exercise 30 minutes a day for 5 days over the next 24 weeks, using a 7 point visual analogue scale.","longName":"DCI_MOTIVATION_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C82975A-09EE-9142-E050-BB89AD4367B9","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"COOPERM","dateModified":"2015-08-20","changeNote":"Created for study in Rave per request by M.Leonard. mc 8/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928873","version":"1","preferredName":"Duke Psychosocial Questionnaire How Confident that You Could Exercise 30 Minutes per Day for 5 Days a Week Over Next 24 Weeks Score 7 Point Visual Analogue Scale","preferredDefinition":"A person's observation of how confident they are that they can exercise 30 minutes a day for 5 days over the next 24 weeks, using a 7 point visual analogue scale.","longName":"DCI_SELF_EFFICACY_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C82975A-0A0F-9142-E050-BB89AD4367B9","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"COOPERM","dateModified":"2015-08-20","changeNote":"Created for study in Rave per request by M.Leonard. mc 8/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4928874","version":"1","preferredName":"Duke Psychosocial Questionnaire Extent of Friend and Family Support of Effort to Increase Amout of Exercise 5 Point Likert Scale","preferredDefinition":"A person's observation of the extent to which their friends and family will support their effort to increase the amount of exercise, using a 5 point Likert scale.","longName":"DCI_SOCL_SUPPORT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C82975A-0A30-9142-E050-BB89AD4367B9","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"COOPERM","dateModified":"2015-08-20","changeNote":"Created for study in Rave per request by M.Leonard. mc 8/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4960946","version":"1","preferredName":"Godin Regular Physical Activity Physical Examination Quality of Life Scale","preferredDefinition":"The response indicating the frequency that regular activity occurred during the timespan of one week.","longName":"GODIN_REG_ACT_SCL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D355AB9-BB92-108A-E050-BB89AD4323C2","latestVersionIndicator":"Yes","beginDate":"2015-08-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-13","modifiedBy":"HARTLEYG","dateModified":"2015-08-13","changeNote":"ExercisePhys_DCI_08.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982451","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE1 Rate Agreement Satisfied with Myself on the Whole Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement satisfied with myself on the whole using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE1_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E172AFF-920C-5FEA-E050-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982452","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE2 Rate Agreement Am No Good at All at Times Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement am no good at all at times using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE2_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E172AFF-922E-5FEA-E050-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982453","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE3 Rate Agreement Have a Number of Good Qualities Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement have a number of good qualities using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE3_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D106-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982454","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE4 Rate Agreement Able to do Things as Well as Most People Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement able to do things as well as most people using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE4_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D12A-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982455","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE5 Rate Agreement Do Not Have Much to be Proud of Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement do not have much to be proud of using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE5_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D14A-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982471","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE6 Rate Agreement Feel Useless at Times Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement feel useless at times using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE6_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D173-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982474","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE7 Rate Agreement Am a Person of Worth on Equal Plane with Others Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement am a person of worth on equal plane with others using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE7_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D193-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982475","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE8 Rate Agreement Wish I Could Have More Respect for Myself Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement wish I could have more respect for myself using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE8_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D1B3-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982476","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE9 Rate Agreement Inclined to Feel That I am a Failure Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement inclined to feel that I am a failure using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE9_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D1D3-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4982477","version":"1","preferredName":"Rosenberg Self-Esteem Scale RSE10 Rate Agreement Take a Positive Attitude Toward Myself Score 4 Point Scale","preferredDefinition":"Persons' stated observation of rated agreement take a positive attitude toward myself using a 4 point Likert scale.","longName":"ROSENBERG_SE_RSE10_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E179889-D1F3-2DC9-E050-BB89AD430DED","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-24","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke clinical trial. dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027151","version":"1","preferredName":"Biopsy Performed Procedure Type","preferredDefinition":"Name of a procedure used to remove tissue specimen(s) or fluid from the body for examination.","longName":"BX_PERF_PROC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20F503DD-B6A6-79A9-E050-BB89AD43740C","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-30","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke Cancer Institute MEL_lpi ILI Protocol with biopsy collection requirements.9.28.2015.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027191","version":"1","preferredName":"Biopsy Other Procedure Performed Type","preferredDefinition":"Text to describe a biopsy procedure used that is different from the one(s) previously specified or mentioned.","longName":"BX_OTX_PROC_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20F503DD-B6EB-79A9-E050-BB89AD43740C","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-30","modifiedBy":"DAVISJ","dateModified":"2016-09-21","changeNote":"Curated to support Duke Cancer Institute MEL_lpi ILI Protocol with biopsy collection requirements.9.28.2015.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027195","version":"1","preferredName":"Clinical Study Sponsor Biopsy Specimen Sent Yes No Indicator","preferredDefinition":"Text term to signify whether a biopsy tissue specimen from a patient was sent to the individual, company, institution, group, or organization functioning as the sponsor of a clinical study.","longName":"SPON_SPEC_RCPT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20F503DD-B72F-79A9-E050-BB89AD43740C","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-30","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke Cancer Institute MEL_lpi ILI Protocol with biopsy collection requirements.9.28.2015.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027201","version":"1","preferredName":"Clinical Study Sponsor Biopsy Specimen Not Sent Text","preferredDefinition":"Text to describe why a biopsy specimen acquired from a patient was not sent to the clinical study sponsor.","longName":"SPON_BX_NOST_RSN_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"20F503DD-B7A1-79A9-E050-BB89AD43740C","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-30","modifiedBy":"REEVESD","dateModified":"2015-10-01","changeNote":"Curated to support Duke Cancer Institute MEL_lpi ILI Protocol with biopsy collection requirements.9.28.2015.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034429","version":"1","preferredName":"Peak Metabolic Equivalent of Task Measurement Value","preferredDefinition":"The response that indicates the value of the highest ratio of metabolic rate during specific physical activity to a reference metabolic rate.","longName":"PK_MET_MEAS_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"22169762-ADF9-5319-E050-BB89AD432C7F","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-10-14","modifiedBy":"HARTLEYG","dateModified":"2015-10-21","changeNote":"ExercisePhys_DCI_10.14.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5034475","version":"1","preferredName":"Respiratory Exchange Ratio Measurement Value","preferredDefinition":"The response indicating the numerical value representing the ratio between the amount of oxygen (O2) consumed and carbon dioxide (CO2) produced in one breath.","longName":"RER_MEAS_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2218DEDB-7BB1-E2C0-E050-BB89AD436604","latestVersionIndicator":"Yes","beginDate":"2015-10-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-10-14","modifiedBy":"HARTLEYG","dateModified":"2015-10-21","changeNote":"ExercisePhys_DCI_10.14.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5036583","version":"1","preferredName":"Ventilatory Threshold Timepoint Type","preferredDefinition":"The response indicating the notable timepoints during exercise at which pulmonary ventilation becomes disproportionately high with respect to oxygen consumption.","longName":"VENT_THRES_TPT_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"22924F10-1F99-E40A-E050-BB89AD433B7E","latestVersionIndicator":"Yes","beginDate":"2015-10-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-10-20","modifiedBy":"HARTLEYG","dateModified":"2015-10-21","changeNote":"ExercisePhys_10.20.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5038736","version":"2","preferredName":"Oxygen Uptake Relative Value Rate","preferredDefinition":"The numeric response that indicates the rate of oxygen consumption measured in ml/kg/min during incremental exercise.","longName":"OXY_UP_REL_VAL_RT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"295D5DE9-3C11-45A3-E050-BB89AD43320D","latestVersionIndicator":"Yes","beginDate":"2016-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"ExercisePhys_DCI_10.27.15_dmr. v2.0 replaces v1.0 to increase overall field length and decimal places. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053443","version":"1","preferredName":"Wound Complication Present Type","preferredDefinition":"The response that indicates a class of medical conditions that develop at the site of an existing wound.","longName":"WOUND_COMP_PRES_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"253E0DBD-470B-EA96-E050-BB89AD434FF8","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-23","modifiedBy":"HARTLEYG","dateModified":"2015-11-24","changeNote":"Wound_DCI_11.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053456","version":"1","preferredName":"Wound Complication Present Other Specify","preferredDefinition":"The response that describes the class of medical conditions that develop at the site of an existing wound that were not previously listed.","longName":"WOUND_COMP_OTH_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"253F6AD4-FEAE-D6CF-E050-BB89AD4342FA","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-23","modifiedBy":"HARTLEYG","dateModified":"2015-11-24","changeNote":"Wound_DCI_11.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053471","version":"1","preferredName":"Specified Bone Or Muscle Involvement Anatomic Site Text","preferredDefinition":"The response that describes the specific connective tissue that forms the skeletal components of the body or the contractile organs of the body that is involved.","longName":"BONE_MUSC_INV_ASIT_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"253F6AD4-FEE9-D6CF-E050-BB89AD4342FA","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-23","modifiedBy":"HARTLEYG","dateModified":"2015-11-24","changeNote":"Wound_DCI_11.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053472","version":"1","preferredName":"Musculoskeletal Tumor Location Anatomic Site","preferredDefinition":"The response that describes the anatomic location of the musculoskeletal tumor.","longName":"MUSCU_TUM_LOC_ASITE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"253F6AD4-FF0A-D6CF-E050-BB89AD4342FA","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-23","modifiedBy":"HARTLEYG","dateModified":"2015-11-24","changeNote":"Wound_DCI_11.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5053473","version":"1","preferredName":"Musculoskeletal Neoplasm Location Anatomic Site Other Specify","preferredDefinition":"The response that describes the location of the musculoskeletal tumor that were not otherwise previously listed.","longName":"MUSCU_LOC_ASITE_OTH_SPEC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"253F6AD4-FF2C-D6CF-E050-BB89AD4342FA","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-23","modifiedBy":"HARTLEYG","dateModified":"2015-11-24","changeNote":"Wound_DCI_11.23.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5103471","version":"1","preferredName":"Hematology Oxygen Saturation Percentage Value","preferredDefinition":"Percentage value determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold.","longName":"HEM_OXS_PTG_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"29640CDC-B7CB-A865-E050-BB89AD433135","latestVersionIndicator":"Yes","beginDate":"2016-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-15","modifiedBy":"REEVESD","dateModified":"2016-01-15","changeNote":"Curated for Duke clinical trials. 1.15.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5144951","version":"1","preferredName":"Implant Failure Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether an object or material, such as an alloplastic or radioactive material or tissue, partially or totally inserted or grafted into the body for prosthetic, therapeutic, diagnostic, or experimental purposes malfunctioned or ceased to function correctly.","longName":"IMPLT_FAIL_OCC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D038C2B-2B4E-1C28-E050-BB89AD4367FB","latestVersionIndicator":"Yes","beginDate":"2016-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-01","modifiedBy":"MORENOC","dateModified":"2017-10-23","changeNote":"Curated to support Duke clinical trial.3.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5144952","version":"1","preferredName":"Implant Failure Occurrence Date","preferredDefinition":"Date on which an object or material, such as an alloplastic or radioactive material or tissue, partially or totally inserted or grafted into the body for prosthetic, therapeutic, diagnostic, or experimental purposes malfunctioned or ceased to function correctly.","longName":"IMPLT_FAIL_OCC_DT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D038C2B-2B6D-1C28-E050-BB89AD4367FB","latestVersionIndicator":"Yes","beginDate":"2016-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-01","modifiedBy":"MORENOC","dateModified":"2017-10-23","changeNote":"Curated to support Duke clinical trial.3.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5144953","version":"1","preferredName":"Reconstructive Surgery Occurrence Yes No Unknown Indicator","preferredDefinition":"Text term to signify whether surgical restoration of function or form of an anatomic site occurred.","longName":"RECONST_SURG_OCC_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D038C2B-2B8C-1C28-E050-BB89AD4367FB","latestVersionIndicator":"Yes","beginDate":"2016-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-01","modifiedBy":"REEVESD","dateModified":"2016-03-03","changeNote":"Curated to support Duke clinical trial.3.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5144976","version":"1","preferredName":"Sarcoma Reconstructive Surgery Type","preferredDefinition":"A classification of surgical reconstruction used for a patient with sarcoma.","longName":"SARC_RECONST_SURG_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D038C2B-2C65-1C28-E050-BB89AD4367FB","latestVersionIndicator":"Yes","beginDate":"2016-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-03-01","modifiedBy":"REEVESD","dateModified":"2016-03-02","changeNote":"Curated to support Duke clinical trial.3.1.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5144977","version":"2","preferredName":"Sarcoma Reconstructive Surgery Other Text","preferredDefinition":"Text to describe a type of surgical reconstruction used for a patient with sarcoma that is different than existing options.","longName":"SARC_REC_SUR_OTX_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCA5B961-3E3A-7CA6-E053-4EBD850AA8CE","latestVersionIndicator":"Yes","beginDate":"2016-03-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-03-03","modifiedBy":"HARTLEYG","dateModified":"2021-03-03","changeNote":"Curated to support Duke clinical trial.3.1.2016.dmr; versioned due to modification of VD and versioning_ghd_03.03.21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5235591","version":"1","preferredName":"EGFR vIII Test Result Positive Negative Not Done Category","preferredDefinition":"Classification to represent the status of a test for EGFR vIII.","longName":"EGFRVIII_RSL_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31748427-1F74-97FA-E050-BB89AD437EBC","latestVersionIndicator":"Yes","beginDate":"2016-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-27","modifiedBy":"MAESKEB","dateModified":"2016-04-27","changeNote":"Curated to support Duke University clinical trial.4/26/2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5235611","version":"1","preferredName":"EGFR vIII Test Percent IHC Result Percentage","preferredDefinition":"Numeric percentage value of EGFR vIII staining by immunohistochemical (IHC) methods.","longName":"EGFRVIII_RSL_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31748427-1F94-97FA-E050-BB89AD437EBC","latestVersionIndicator":"Yes","beginDate":"2016-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-27","modifiedBy":"MAESKEB","dateModified":"2016-04-27","changeNote":"Curated to support Duke University clinical trial. 4.26.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5235631","version":"1","preferredName":"EGFR vIII Test PCR Scoring Result Present Absent Not Done Category","preferredDefinition":"Classification to represent the status of EGFR vIII Polymerase Chain Reaction (PCR) testing.","longName":"EGFRVIII_SC_PRES_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31748427-1FB4-97FA-E050-BB89AD437EBC","latestVersionIndicator":"Yes","beginDate":"2016-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-27","modifiedBy":"MAESKEB","dateModified":"2016-04-27","changeNote":"Curated to support Duke University clinical trial.4.27.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5235651","version":"1","preferredName":"EGFR vIII Test Percent Unit CD3 Result Percentage Value","preferredDefinition":"Numeric percentage value to represent the amount of CD3+ present in EGFR vIII test result.","longName":"EGFRVIII_CD3_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31748427-1FD4-97FA-E050-BB89AD437EBC","latestVersionIndicator":"Yes","beginDate":"2016-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-27","modifiedBy":"MAESKEB","dateModified":"2016-04-27","changeNote":"Curated to support Duke University clinical trial.4.27.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5235691","version":"1","preferredName":"EGFR vIII Test Immunohistochemistry Staining Score","preferredDefinition":"Numeric score to describe the result of immunohistochemical (IHC) testing of EGFR vIII.","longName":"EGFRVIII_IHC_STN_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"31748427-2098-97FA-E050-BB89AD437EBC","latestVersionIndicator":"Yes","beginDate":"2016-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-27","modifiedBy":"MAESKEB","dateModified":"2016-04-27","changeNote":"Curated to support Duke University clinical trial.4.27.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5296991","version":"1","preferredName":"No Childbearing Potential Reason Text","preferredDefinition":"Text to capture an explanation for a female's inability to become pregnant.","longName":"NO_CHBR_POT_RSN_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3568AE14-DD12-1E78-E050-BB89AD4375DB","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-16","modifiedBy":"COOPERM","dateModified":"2018-02-16","changeNote":"Curated to support Duke Cancer Institute (DCI) GYN Trial.6.24.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5297024","version":"1","preferredName":"BRCA1 Gene BRCA2 Gene Testing Status Complete Yes No Indicator","preferredDefinition":"Text term to signify whether testing for BRCA1 and BRCA2 Gene presence is complete.","longName":"BRCA_GENE_COMP_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"35692FC2-3941-BCAB-E050-BB89AD434EDC","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-16","modifiedBy":"VUJANOVA","dateModified":"2019-09-07","changeNote":"Curated to support Duke Cancer Institute (DCI) GYN Trial.6.24.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5297235","version":"1","preferredName":"Laboratory Assay Analysis Not Complete Reason Text","preferredDefinition":"Text explanation for the lack of completion of a laboratory assay or test.","longName":"LAB_ASY_NCOM_RSN_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"356A04FE-3FBC-CAB5-E050-BB89AD431E3D","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-16","modifiedBy":"COOPERM","dateModified":"2017-02-15","changeNote":"Curated to support Duke Cancer Institute CRF.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5300831","version":"1","preferredName":"BRCA1 Gene BRCA2 Gene Mutation Testing Status","preferredDefinition":"State of BRCA1 and BRCA2 gene mutation testing.","longName":"BRCA1_2_MUT_TST_STAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"35BA9078-1881-BBA8-E050-BB89AD4355B5","latestVersionIndicator":"Yes","beginDate":"2016-06-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-20","modifiedBy":"TITARENKOI","dateModified":"2020-06-30","changeNote":"Curated to support Duke Cancer Institute (DCI) GYN Trial.6.24.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5306216","version":"1","preferredName":"Tumor Debulking Extent Category","preferredDefinition":"Classification to describe the magnitude of tumor removal following a surgical procedure.","longName":"TUM_DEBLK_EXT_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"35E1BCD6-802F-E060-E050-BB89AD43288C","latestVersionIndicator":"Yes","beginDate":"2016-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-22","modifiedBy":"REEVESD","dateModified":"2016-06-24","changeNote":"Curated to support Duke Cancer Institute (DCI) GYN Trial.6.24.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5314991","version":"1","preferredName":"Investigational Drug Infusion Reaction Occurrence Indicator","preferredDefinition":"Text to signify whether a patient experienced an infusion reaction associated with the infusion of an investigational agent.","longName":"INV_AGT_INF_RCT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"360CB9E7-48C1-0333-E050-BB89AD435D1F","latestVersionIndicator":"Yes","beginDate":"2016-06-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-06-24","modifiedBy":"REEVESD","dateModified":"2016-06-27","changeNote":"Curated to support Duke Cancer Institute (DCI) clinical trial.6.24.2016.dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350737","version":"1","preferredName":"Controlled Oral Word Association Test Trial 1 Correct Word Result Count","preferredDefinition":"Number of correct responses for the first trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL1_RSL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC6A9E-62DC-1D29-E050-BB89AD432DB5","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350738","version":"1","preferredName":"Controlled Oral Word Association Test Trial 1 Inadmissible Words Result Count","preferredDefinition":"Number of inadmissible answers for the first trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL1_INADM_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC6A9E-62FB-1D29-E050-BB89AD432DB5","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350739","version":"1","preferredName":"Controlled Oral Word Association Test Trial 2 Correct Words Result Count","preferredDefinition":"Number of correct answers for the second trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL2_RSL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC6A9E-631A-1D29-E050-BB89AD432DB5","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350740","version":"1","preferredName":"Controlled Oral Word Association Test Trial 2 Inadmissible Words Result Count","preferredDefinition":"Number of inadmissible answers for the second trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL2_INADM_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC8689-A95A-905C-E050-BB89AD434979","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350741","version":"1","preferredName":"Controlled Oral Word Association Test Trial 3 Inadmissible Words Result Count","preferredDefinition":"Number of inadmissible answers for the third trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL3_INADM_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC8689-A979-905C-E050-BB89AD434979","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350743","version":"1","preferredName":"Controlled Oral Word Association Test Trial 3 Correct Word Result Count","preferredDefinition":"Number of correct answers for the third trial with the Controlled Oral Word Association Test (COWAT) based on the recall of words that start with a specific letter.","longName":"COWAT_TRL3_RSL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC8689-A9BB-905C-E050-BB89AD434979","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350744","version":"1","preferredName":"Controlled Oral Word Association Test Result Raw Score","preferredDefinition":"Total score for all three trials with the Controlled Oral Word Association Test or COWAT.","longName":"COWAT_TTL_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC8689-A9DA-905C-E050-BB89AD434979","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"CLOHNES","dateModified":"2023-11-06","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":"11/06/23 Added AQT for CCTG ticket number CADSR0003034 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350746","version":"1","preferredName":"Controlled Oral Word Association Test Adjusted Score","preferredDefinition":"Total score for all three trials on the Controlled Oral Word Association Test (COWAT) adjusted for age and education level.","longName":"COWAT_ADJUST_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"37EC8689-A9F9-905C-E050-BB89AD434979","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support Duke clinical trial CRF creation.7.10.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5350761","version":"1","preferredName":"Person Education Years Completed Number","preferredDefinition":"Total number of years of education a person has completed.","longName":"PER_EDUC_YR_COMP_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"37ECF63E-E0DF-9AB5-E050-BB89AD430C72","latestVersionIndicator":"Yes","beginDate":"2016-07-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-18","modifiedBy":"COOPERM","dateModified":"2017-02-15","changeNote":"Curated to support Duke Cancer Institute CRF.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365403","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Form Identifier","preferredDefinition":"Indication by form number of the type of Hopkins Verbal Learning Test-Revised (HVLT-R) test administered.","longName":"HVLTR_FORM_ID","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A26142-2732-4FE3-E050-BB89AD4362F6","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365404","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Trial 1 Raw Score","preferredDefinition":"Number of responses during first trial of the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_TL1_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A3A477-E6EF-670C-E050-BB89AD430950","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365405","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Trial 2 Raw Score","preferredDefinition":"Number of responses during second trial of the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_TL2_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A26142-2751-4FE3-E050-BB89AD4362F6","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365406","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Trial 3 Raw Score","preferredDefinition":"Number of responses during third trial of the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_TL3_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A26142-277E-4FE3-E050-BB89AD4362F6","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365407","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Recall Score","preferredDefinition":"Value representing the sum of correct responses from trials one through three from the Hopkins Verbal Learning Test-Revised or HVLT-R when administered to a single individual.","longName":"HTLVR_RECL_RAW SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A26142-27CD-4FE3-E050-BB89AD4362F6","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365411","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Total Recall T-Score","preferredDefinition":"T-score value correlated to the raw score from the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HTLVR_RECL_TSCORE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A3D822-3627-1522-E050-BB89AD43409A","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365416","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Trial 4 Delayed Recall Score","preferredDefinition":"Numeric value representing responses recalled by an individual 20 to 25 minutes after the administration of the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_TRL4_DEL_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A3D822-3646-1522-E050-BB89AD43409A","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365417","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Trial 4 Delayed Recall T-Score","preferredDefinition":"T-score correlated to the responses recalled by an individual 20 to 25 minutes after the administration of the Hopkins Verbal Learning Test-Revised or HVLT-R, referred to as the delayed recall score.","longName":"HVLTR_TRL4_DEL_TSC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A3D822-3665-1522-E050-BB89AD43409A","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365434","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Retention Percentage Value","preferredDefinition":"Percentage value based on result of trial 4 of Hopkins Verbal Learning Test-Revised or HVLT-R divided by higher score of trials 2 and 3 then multiplied by 100.","longName":"HTLVR_RETN_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A3D822-36B8-1522-E050-BB89AD43409A","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365471","version":"1","preferredName":"Hopkins Verbal Learning Test-Revised Retention T-score","preferredDefinition":"T-score correlated to the Hopkins Verbal Learning Test-Revised or HVLT-R retention score (based on result of trial 4 divided by higher score of trials 2 and 3 then multiplied by 100).","longName":"HVLTR_RETN_TSC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A45C32-8241-A01B-E050-BB89AD431EDB","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365472","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Raw Positive Hits Total Score","preferredDefinition":"Number of correct responses out of twelve (12) responses on the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_POS_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A46D90-E3FD-5B56-E050-BB89AD4309BE","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365473","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Related False Positive Raw Score","preferredDefinition":"Number of semantically related false positive errors made on the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_FAL_POS_RAW_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38A47DDF-44F0-1BE9-E050-BB89AD4333A3","latestVersionIndicator":"Yes","beginDate":"2016-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-27","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365571","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Unrelated False Positive Unrelated Score","preferredDefinition":"Number of semantically unrelated false positive errors made on the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_UNR_FAL_POS_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B20C5D-4E63-3B26-E050-BB89AD430999","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365572","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Recognition False Positive Score","preferredDefinition":"Total number of false positive errors made by an individual taking the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_RECOG_FLS_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B20C5D-4E82-3B26-E050-BB89AD430999","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365573","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Recognition Discrimination Index Score","preferredDefinition":"Total number of true positive responses less the number of total number of false positive responses on the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_RECOG_INDEX_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B20C5D-4EA1-3B26-E050-BB89AD430999","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365574","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Recognition Discrimination Index T-Score","preferredDefinition":"T-score correlated to the recognition discrimination index score for an individual taking the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_RECOG_INDX_TSC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B20C5D-4EC0-3B26-E050-BB89AD430999","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5365575","version":"1","preferredName":"Hopkins Verbal Learning Test Revised Normative Table Identifier","preferredDefinition":"Identifier for the normative table used to analyze data from the administration of the Hopkins Verbal Learning Test-Revised or HVLT-R.","longName":"HVLTR_NORM_TAB_ID","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"HVLT-R:Hopkins Verbal Learning Test-Revised, Jason Brandt, PhD, 1991","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38B20C5D-4EDF-3B26-E050-BB89AD430999","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"REEVESD","dateModified":"2016-07-29","changeNote":"Curated to support HVLT-R CRF for Duke clinical trial.7.28.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434353","version":"1","preferredName":"COWAT Adjusted Result Percentile Rank Value","preferredDefinition":"Numeric percentile rank of a person's adjusted Controlled Oral Word Association Test (COWAT) score based on a normalization table (or manual) of scores for various populations.","longName":"COWAT_PERC_RANK_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"COWAT:Controlled Oral Word Association Test","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B37BF09-D3F9-260B-E050-BB89AD432345","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-29","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeNote":"Curated to support Duke clinical trial.8.29.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566174","version":"1","preferredName":"Tumor Cell Folate Receptor Alpha Staining Positive Percentage Value","preferredDefinition":"Cells of, or derived from, a tumor._Folate receptor alpha (257 aa, ~30 kDa) is encoded by the human FOLR1 gene. This protein is involved in cellular import of folate, 5-methyltetrahydrofolate, and folic acid derivatives._Any of the various methods that use a dye, reagent, or other material for producing coloration in tissues or microorganisms for microscopic examination._Confirmation of something, such as a positive lab test. In medicine, a positive lab test indicates the presence of a disease, condition, or microorganism. (NCI)_The individual unit that makes up all of the tissues of the body. All living things are made up of one or more cells._Percentage; a fraction or ratio with 100 understood as the denominator.","longName":"FRA_STAIN_PC_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"407C2088-5453-0233-E053-F662850A546B","latestVersionIndicator":"Yes","beginDate":"2016-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-04","modifiedBy":"REEVESD","dateModified":"2016-11-04","changeNote":"Curated to support Duke Cancer Center clinical trial.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566175","version":"1","preferredName":"Tumor Cell Folate Receptor Alpha Staining Intensity Score","preferredDefinition":"Expression of the staining intensity of Folate Receptor Alpha expression testing.","longName":"FRA_STAIN_INTNS_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"407C2088-5463-0233-E053-F662850A546B","latestVersionIndicator":"Yes","beginDate":"2016-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-04","modifiedBy":"REEVESD","dateModified":"2016-11-04","changeNote":"Curated to support Duke Cancer Institute CRF.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566176","version":"1","preferredName":"Tumor Cell Folate Receptor Alpha Staining True Score","preferredDefinition":"Numeric value representing the Folate Receptor Alpha true score, which is calculated as the sum of (Folate Receptor Alpha percentage of stained cells) multiplied by the (specific staining intensity).","longName":"FRA_STAIN_H_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"407C36A3-D35C-1EA2-E053-F662850AC7F6","latestVersionIndicator":"Yes","beginDate":"2016-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-04","modifiedBy":"COOPERM","dateModified":"2017-02-15","changeNote":"Curated to support Duke Cancer Center clinical trial.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566184","version":"1","preferredName":"Right Lymph Node Visible Gamma Camera Measurement Yes No Indicator","preferredDefinition":"Text term to signify the presence of dye in the right lymph node seen by gamma camera.","longName":"RLN_VIS_GAMCAM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"407C4F0F-0E1F-5973-E053-F662850AAE53","latestVersionIndicator":"Yes","beginDate":"2016-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-04","modifiedBy":"REEVESD","dateModified":"2016-11-04","changeNote":"Curated to support Duke Cancer Center clinical trial.11.4.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566185","version":"1","preferredName":"Left Lymph Node Visible Gamma Camera Measurement Yes No Indicator","preferredDefinition":"Text term to signify the presence of dye in the left lymph node seen by gamma camera.","longName":"LFT_VIS_CAMCAM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"407C36A3-D37B-1EA2-E053-F662850AC7F6","latestVersionIndicator":"Yes","beginDate":"2016-11-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-04","modifiedBy":"REEVESD","dateModified":"2016-11-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566398","version":"1","preferredName":"Patient Antiemetic Preference Agent Name","preferredDefinition":"Text term to identify a nausea/vomiting medication with which the patient was most satisfied.","longName":"PT_ANTIEMET_PREF_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"40B87ED6-7405-6365-E053-F662850AF15A","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-07","modifiedBy":"REEVESD","dateModified":"2016-11-07","changeNote":"Curated to support Duke Cancer Institute protocol.11.7.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5578389","version":"1","preferredName":"Neoplastic Cell Folate Receptor Alpha Staining Additive Percentage Value","preferredDefinition":"Additive value of Percentage of tumor cells with membrane and cytoplasmic staining for Folate Receptor Alpha expression based on staining intensity (1+, 2+, 3+).    The value is B+C+D where B=% of cells with 1+ positive staining, and C= %of cells with 2+ positive staining, and D= %of cells with 3+ positive staining.","longName":"ADD_FRA_STAIN_PC_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"418462FF-DB2B-589A-E053-F662850AA273","latestVersionIndicator":"Yes","beginDate":"2016-11-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-11-17","modifiedBy":"SBR","dateModified":"2016-11-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604025","version":"1","preferredName":"EGFR IHC Result Status","preferredDefinition":"Text term that represents the status of the Epidermal Growth Factor Receptor (EGFR) Immunohistochemistry (IHC) result or reason for the lack of a result.","longName":"EGFR_IHC_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D6E3-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604026","version":"1","preferredName":"EGFR wt IHC Staining Score","preferredDefinition":"Numeric score that represents the strength of the Immunohistochemistry (IHC) staining for Epidermal Growth Factor Receptor wild type (EGFR wt).","longName":"EGFR_WT_IHC_SCR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D704-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604027","version":"1","preferredName":"EGFR wt IHC Result Percentage Integer","preferredDefinition":"Numeric representation of the percentage of tumor cells exhibiting staining of Epidermal Growth Factor Receptor wild type (EGFR wt).","longName":"EGFR_WT_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"439580F6-A4A0-7C21-E053-F662850A822A","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604028","version":"1","preferredName":"EGFRvIII IHC Result Status","preferredDefinition":"Text term that represents the status of the Epidermal Growth Factor Receptor variant 3 (EGFRvIII) Immunohistochemistry (IHC) result or reason for the lack of a result.","longName":"EGFRVIII_IHC_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"439580F6-A4C1-7C21-E053-F662850A822A","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604029","version":"1","preferredName":"MGMT IHC Result Status","preferredDefinition":"Text term that represents the status of the O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemistry (IHC) result or reason for the lack of a result.","longName":"MGMT_IHC_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"439580F6-A4E2-7C21-E053-F662850A822A","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604030","version":"1","preferredName":"MGMT IHC Result Percentage Integer","preferredDefinition":"Numeric representation of the percentage of tumor cells exhibiting staining of O-6-methylguanine-DNA methyltransferase (MGMT).","longName":"MGMT_IHC_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"439580F6-A503-7C21-E053-F662850A822A","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604031","version":"1","preferredName":"MGMT Promoter Methylation Result Status","preferredDefinition":"Text term that represents the status of the O-6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation result or reason for the lack of a result.","longName":"MGMT_PRO_MTHYL_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395D1A3-9CD2-5500-E053-F662850A92B0","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"KUMMEROA","dateModified":"2021-07-14","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604032","version":"1","preferredName":"IDH1 PCR Result Status","preferredDefinition":"Text term that represents the status of the Isocitrate dehydrogenase 1 (NADP+), soluble Polymerase chain reaction (PCR) result or reason for the lack of a result.","longName":"IDH1_PCR_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395D1A3-9CF3-5500-E053-F662850A92B0","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604037","version":"1","preferredName":"IDH1 R132H Finding Result","preferredDefinition":"Text term that represents the qualitative result of the IDH1 R132H point mutation present in more than 70% of all gliomas.","longName":"IDH1_R132H_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D74F-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604038","version":"1","preferredName":"IDH1 Molecular Diagnostics Result Status","preferredDefinition":"Text term that describes the mutation or intact status of genes within the IDH1 enzyme.","longName":"IDH1_MD_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D770-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604039","version":"1","preferredName":"IDH2 Molecular Diagnostics Result Status","preferredDefinition":"Text term that describes the mutation or intact status of genes within the IDH2 enzyme.","longName":"IDH2_MD_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395D1A3-9D14-5500-E053-F662850A92B0","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604040","version":"1","preferredName":"TERT PCR Result Status","preferredDefinition":"Text term that represents the status of the Telomerase reverse transcriptase (TERT) Polymerase chain reaction (PCR) result or reason for the lack of a result.","longName":"TERT_PCR_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D791-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604041","version":"1","preferredName":"TERT Molecular Diagnostics Result Status","preferredDefinition":"Text term that describes the mutation or intact status of genes within the TERT enzyme.","longName":"TERT_MD_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395D1A3-9D35-5500-E053-F662850A92B0","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604042","version":"1","preferredName":"PVR IHC Result Status","preferredDefinition":"Text term that represents the status of the Polio Virus Receptor  (PVR) Immunohistochemistry (IHC) result or reason for the lack of a result.","longName":"PVR_IHC_RSLT_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4395566F-D7B2-5287-E053-F662850AB237","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-13","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604118","version":"1","preferredName":"IDH1 Mutation Gene Name","preferredDefinition":"Name that describes the gene related to IDH1 mutation.","longName":"IDH1_MUT_GENE_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43A1EE76-8C0A-6C72-E053-F662850AC5CA","latestVersionIndicator":"Yes","beginDate":"2016-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-14","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604119","version":"1","preferredName":"IDH2 Mutation Gene Name","preferredDefinition":"Name that describes the gene related to IDH2 mutation.","longName":"IDH2_MUT_GENE_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43A1EE76-8C41-6C72-E053-F662850AC5CA","latestVersionIndicator":"Yes","beginDate":"2016-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-14","modifiedBy":"SOKKERL","dateModified":"2019-12-12","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5604120","version":"1","preferredName":"TERT Mutation Gene Name","preferredDefinition":"Name that describes the gene related to TERT mutation.","longName":"TERT_MUT_GENE_NM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43A1DB61-2128-6C7D-E053-F662850AA820","latestVersionIndicator":"Yes","beginDate":"2016-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-14","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607224","version":"1","preferredName":"IHC 3+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric representation of the percentage of Immunohistochemistry (IHC) staining of 3+ for Polio Virus Receptor (PVR).","longName":"PVR3+STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43CDFDE8-B43A-6309-E053-F662850AB5B4","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-16","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/16/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607249","version":"1","preferredName":"IHC 2+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric representation of the percentage of Immunohistochemistry (IHC) staining of 2+ for Polio Virus Receptor (PVR).","longName":"PVR2+STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43CEF06E-3E0E-5D29-E053-F662850A33F4","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-16","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/16/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5607264","version":"1","preferredName":"IHC 1+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric representation of the percentage of Immunohistochemistry (IHC) staining of 1+ for Polio Virus Receptor (PVR).","longName":"PVR1+STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43CEF06E-3E2F-5D29-E053-F662850A33F4","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-16","modifiedBy":"COOPERM","dateModified":"2016-12-19","changeNote":"Created for IHC Monitoring form for brain cancer study in Rave as requested by M. Leonard. mc 12/16/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610327","version":"1","preferredName":"Autopsy Brain Obtained Indicator","preferredDefinition":"Indicator of whether or not the brain was obtained at autopsy for research purposes.","longName":"AUTPSY_BRAIN_OBT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4448B828-B682-1C7C-E053-F662850A4C8D","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-22","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for 018 Brain Autopsy form as requested by M. Leonard. mc 12/22/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610330","version":"1","preferredName":"Autopsy Brain Identifier","preferredDefinition":"Numeric identifier assigned to the subject autopsy.","longName":"AUTOPSY_BRAIN_ID","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4448B7B3-C4CF-1B94-E053-F662850A6AE4","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-22","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for 018 Brain Autopsy form as requested by M. Leonard. mc 12/22/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610333","version":"1","preferredName":"Autopsy Brain Nautilus LMIS Identifier","preferredDefinition":"Alphanumeric assigned by Nautilus LIMS (laboratory information management system).","longName":"AUTOPSY_NTS_LIMS_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4448B7B3-C4F0-1B94-E053-F662850A6AE4","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-22","modifiedBy":"COOPERM","dateModified":"2016-12-30","changeNote":"Created for 018 Brain Autopsy form as requested by M. Leonard. mc 12/22/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5632095","version":"1","preferredName":"Lesion Successful LITT Treatment MRI Result Percent Value","preferredDefinition":"Numeric representation of the percentage of the lesion that was successfully treated using the Laser Interstitial Thermal Therapy procedure.","longName":"LSN_LITT_MRI_PRCT_VL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"468E1341-567C-4D0B-E053-F662850A5DBC","latestVersionIndicator":"Yes","beginDate":"2017-01-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-20","modifiedBy":"COOPERM","dateModified":"2017-01-30","changeNote":"Created for LITT Form for study in Rave. mc 1/20/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664732","version":"1","preferredName":"Pelvis Disease Extent Prior to Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in pelvis prior to cytoreduction.","longName":"PELVIS_PR_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4883A33F-9BEC-6FB1-E053-F662850A6D54","latestVersionIndicator":"Yes","beginDate":"2017-02-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-14","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/14/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664770","version":"1","preferredName":"Mid-Abdomen Disease Extent Prior to Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in mid-abdomen prior to cytoreduction.","longName":"MABD_PR_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48924151-F2F4-3EE6-E053-F662850A858B","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/14/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664771","version":"1","preferredName":"Upper-Abdomen Disease Extent Prior to Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in upper-abdomen prior to cytoreduction.","longName":"UABD_PR_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48924622-DDC1-681F-E053-F662850AA654","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/15/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664772","version":"1","preferredName":"Pelvis Disease Extent After Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in the pelvis after cytoreduction.","longName":"PELVIS_PO_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48924622-DDE1-681F-E053-F662850AA654","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/15/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664773","version":"1","preferredName":"Mid-Abdomen Disease Extent After to Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in mid-abdomen after cytoreduction.","longName":"MABD_PO_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48924151-F314-3EE6-E053-F662850A858B","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/15/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664774","version":"1","preferredName":"Upper-Abdomen Disease Extent After to Cytoreduction Type","preferredDefinition":"Text term for the extent of disease in upper-abdomen after cytoreduction.","longName":"UABD_PO_CYTRDC_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48924151-F334-3EE6-E053-F662850A858B","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/15/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5664775","version":"1","preferredName":"Peritoneal Washings Collected Indicator","preferredDefinition":"An indication of whether peritoneal washings were collected.","longName":"PERITN_WASH_COLL_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48925D0C-7E48-2D01-E053-F662850AE02B","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-02-15","modifiedBy":"COOPERM","dateModified":"2017-02-17","changeNote":"Created for GYN Surgery form. mc 2/15/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702411","version":"1","preferredName":"Laboratory Procedure ELISA Keyhole Limpet Hemocyanin Result Value","preferredDefinition":"Numeric representation of the amount of Keyhole Limpet hemocyanin (KLH) using ELISA (enzyme-linked immunosorbent assay).","longName":"LAB_KLH_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A5FCC47-CF39-75F4-E053-F662850A3FC9","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for study in Rave. mc 3/10/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702412","version":"1","preferredName":"Laboratory Procedure ELISA Cytomegalovirus Glycoprotein B Result Value","preferredDefinition":"Numeric representation of the amount of human cytomegalovirus glycoprotein B (gB) using ELISA (enzyme-linked immunosorbent assay).","longName":"LAB_GB_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A616BC1-85F9-2280-E053-F662850A4486","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for study in Rave. mc 3/10/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702414","version":"1","preferredName":"Dynamic Contrast-Enhanced Magnetic Resonance Imaging Extravascular Extracellular Volume Fraction Result Value","preferredDefinition":"Numeric representation of the extravascular extracellular volume fraction (amount of contrast that has leaked out of vessels) using DCE (Dynamic Contrast Enhanced imaging).","longName":"DCE_VE_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A61D10D-2F0B-440F-E053-F662850A42B1","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-27","changeNote":"Created for study in Rave. mc 3/10/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5768520","version":"1","preferredName":"Histology Cytopathology Involvement Percentage Value","preferredDefinition":"Numeric representation for the histology cytopathology involvement measured in percent.","longName":"HIST_CYTOP_INV_VL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CFEE15A-A3BF-2A5E-E053-F662850ACFA7","latestVersionIndicator":"Yes","beginDate":"2017-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-12","modifiedBy":"KUMMEROA","dateModified":"2023-11-30","changeNote":"Created for GU_ASSET X form request on 10Apr. mc","administrativeNotes":"2023.11.30 AQT/Alt SN added per ticket request CADSR0003111. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5768552","version":"1","preferredName":"Echocardiogram Evaluation Exercise Stage Category","preferredDefinition":"Text term that describes the evaluation stage of during the echocardiogram evaluation.","longName":"ECHO_EVAL_STG_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CFF6149-6EA1-1C6B-E053-F662850AD6F6","latestVersionIndicator":"Yes","beginDate":"2017-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-12","modifiedBy":"COOPERM","dateModified":"2017-04-13","changeNote":"Created for GU_ASSET X form request on 10Apr. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5768555","version":"1","preferredName":"Echocardiogram Test Type","preferredDefinition":"Text term that represents the kind of echocardiogram test.","longName":"ECHO_TST_TP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CFF2EFF-2C7A-25FB-E053-F662850A04AB","latestVersionIndicator":"Yes","beginDate":"2017-04-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-12","modifiedBy":"COOPERM","dateModified":"2017-04-13","changeNote":"Created for GU_ASSET X form request on 10Apr. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5806257","version":"1","preferredName":"BRCA1 Gene BRCA2 Gene Laboratory Testing Result Text","preferredDefinition":"Test describing specific findings for BRCA1/BRCA2 tumor suppressor gene.","longName":"BRCA_TEST_RESULT_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EA20430-56BF-4FA5-E053-F662850A7A34","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-03","modifiedBy":"HARTLEYG","dateModified":"2017-05-03","changeNote":"Curated to support GYN study for DCI_ghd_05.03.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5806259","version":"1","preferredName":"Homologous Recombination Deficiency Testing Performed Indicator","preferredDefinition":"Indicator as to whether homologous recombination deficiency testing was performed.","longName":"HRD_TEST_PRF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EA1CC5C-4932-480C-E053-F662850A1139","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-03","modifiedBy":"HARTLEYG","dateModified":"2017-05-03","changeNote":"Curated to support GYN study for DCI_ghd_05.03.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5806260","version":"1","preferredName":"Homologous Recombination Deficiency Laboratory Testing Result Text","preferredDefinition":"Text describing specific findings for homologous recombination deficiency testing.","longName":"HRD_TEST_RESULT_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EA1AA5C-2644-4C10-E053-F662850ABDEF","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-03","modifiedBy":"HARTLEYG","dateModified":"2017-05-03","changeNote":"Curated to support GYN study for DCI_ghd_05.03.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823073","version":"1","preferredName":"Tracer Radioactivity Above Background Radioactivity Detection Indicator","preferredDefinition":"The response that indicates whether single photon emission computed tomography radioactivity was detected relative to the background radioactivity.","longName":"TRAC_ABV_BCK_RAD_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F41FDA9-94E8-147B-E053-F662850A0539","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated for RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823074","version":"1","preferredName":"Neoplasm Radioactivity Count per Minute Detection Value","preferredDefinition":"The single photon emission computed tomography tumor count.","longName":"TUM_RAD_CNT_MIN_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F46FBAD-325A-1169-E053-F662850A06BD","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823075","version":"1","preferredName":"Background Radioactivity Count per Minute Detection Value","preferredDefinition":"The single photon emission computed tomography background count.","longName":"BCK_RAD_COUNT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F47554F-6462-7F76-E053-F662850A65F8","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823076","version":"1","preferredName":"Imaging Technique Single Photon Emission Computed Tomography Complete Indicator","preferredDefinition":"The response indicating whether single photon emission computed tomography testing was completed.","longName":"SPECT_COMP_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F41FDA9-9509-147B-E053-F662850A0539","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823077","version":"1","preferredName":"Background Tissue Standardized Uptake Value Mean Number","preferredDefinition":"The response that indicates the background standard uptake value mean.","longName":"BCK_SUV_MEAN_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F48A255-7094-3D05-E053-F662850AE043","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823078","version":"1","preferredName":"Background Tissue Standardized Uptake Value Maximum Number","preferredDefinition":"The response that indicates the background tissue standard uptake value maximum.","longName":"BCK_SUV_MAX_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F4ACD77-D3D6-391B-E053-F662850A65A0","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5823079","version":"1","preferredName":"Positron Emission Tomography Scan Procedure Directionality Type","preferredDefinition":"The response that indicates the direction of the PET scan.","longName":"PET_SCAN_PRO_DIR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F4AD4CC-5F2A-391D-E053-F662850A1A55","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-05-11","modifiedBy":"HARTLEYG","dateModified":"2017-05-12","changeNote":"Curated to support RAVE Brain study_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5895901","version":"1","preferredName":"Target Lesion Identification Immune-Modified Response Evaluation Criteria in Solid Tumors Disease Response Type","preferredDefinition":"Text code to represent disease response in a target lesion, using iRECIST response criteria.","longName":"TGTLES_IRECIST_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53BAE25F-905F-75B7-E053-F662850A21F8","latestVersionIndicator":"Yes","beginDate":"2017-07-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-07","modifiedBy":"HARTLEYG","dateModified":"2017-07-21","changeNote":"Curated to support Immunotherapy Response Protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914112","version":"1","preferredName":"Non-Target Lesion Identification Immune-Modified Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"Text code to represent disease response in a non-target lesion, using iRECIST response criteria.","longName":"NTGTLES_IRECIST_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54A0C8BD-13C0-4731-E053-F662850AFAC7","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-18","modifiedBy":"HARTLEYG","dateModified":"2017-07-21","changeNote":"Curated to support Immunotherapy Response Protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914116","version":"1","preferredName":"New Lesion Identification Immune-Modified Response Evaluation Criteria in Solid Tumors Disease Response Immune-Modified Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"Text code to represent disease response in a new lesion, using iRECIST response criteria.","longName":"NEWLES_IRECIST_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54A0ED3C-B583-78B4-E053-F662850AC665","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-18","modifiedBy":"HARTLEYG","dateModified":"2017-07-21","changeNote":"Curated to support Immunotherapy Response Protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914120","version":"1","preferredName":"Solid Neoplasm Immune-Modified Response Evaluation Criteria in Solid Tumors Assessment Overall Disease Response Type","preferredDefinition":"Text code to represent overall disease response in solid tumors during an assessment, using iRECIST response criteria.","longName":"NEO_IRECIST_OVR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54A0F3F9-C38F-7E9F-E053-F662850A104C","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-18","modifiedBy":"MORENOC","dateModified":"2017-10-03","changeNote":"Curated to support Immunotherapy Response Protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5914123","version":"1","preferredName":"Solid Neoplasm Immune-Modified Response Evaluation Criteria in Solid Tumors Best Overall Response Type","preferredDefinition":"Text code to represent the best overall disease response in solid tumors since the beginning of the study, using iRECIST response criteria.","longName":"IRECIST_BEST_OVR_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54A13125-DDC3-7B9E-E053-F662850A5059","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-18","modifiedBy":"TAYLORT","dateModified":"2017-10-30","changeNote":"Curated to support Immunotherapy Response Protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935953","version":"1","preferredName":"SPECT Whole Body Planar Imaging Performed Indicator","preferredDefinition":"Indicator of whether or not planar whole body SPECT imaging was performed.","longName":"SPECT_WB_PLN_IMG_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5722269B-7E80-5375-E053-F662850A4DE7","latestVersionIndicator":"Yes","beginDate":"2017-08-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-19","modifiedBy":"COOPERM","dateModified":"2017-08-28","changeNote":"Created for SPECT data set for study in Rave. 8/18/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935954","version":"1","preferredName":"PET Imaging Signal Diffusion Topography Location Text","preferredDefinition":"Text to describe the different topographical locations within the body by diffusion of PET imaging signal.","longName":"PET_SIG_DIFF_LOC_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5722269B-7EA2-5375-E053-F662850A4DE7","latestVersionIndicator":"Yes","beginDate":"2017-08-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-08-19","modifiedBy":"COOPERM","dateModified":"2017-08-28","changeNote":"Created for SPECT data set for study in Rave. 8/18/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6025359","version":"1","preferredName":"Simplified Preoperative Assessment for Appendix Tumor Score","preferredDefinition":"The score used to determine the likelihood of complete cytoreduction in patients with low-grade mucinous adenocarcinoma (LGMA) of the appendix based on preoperative scans.","longName":"SPAAT_SCORE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D6FEC73-C4C7-6366-E053-F662850A7AD2","latestVersionIndicator":"Yes","beginDate":"2017-11-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-07","modifiedBy":"HARTLEYG","dateModified":"2017-11-08","changeNote":"Curated to support DCI GU and GI studies_11.07.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6078058","version":"1","preferredName":"Homologous Recombination Deficiency Testing Outcome Laboratory Result Status","preferredDefinition":"The response that describes the specific findings for homologous recombination deficiency testing.","longName":"HRD_TEST_RSLT_STATUS","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D1AAB3-E96B-626A-E053-F662850A6852","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-22","modifiedBy":"HARTLEYG","dateModified":"2018-02-22","changeNote":"Curated to support GYN study for DCI_ghd_02.22.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6155916","version":"1","preferredName":"Trail Making Test Normative Data Score","preferredDefinition":"The numerical response that indicates the normalized score of an individual completing the Trail Making Test.  The normative score is the calculated result of the mean time for completion of the test (seconds) minus the time for completion (seconds) divided by the standard deviation.","longName":"TRAILMK_NORM_DAT_SC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"Trail Making Test by US Army, 1944 as part of the  Army Individual Test of General Ability","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68913288-8182-7449-E053-F662850A17DA","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-29","modifiedBy":"HARTLEYG","dateModified":"2018-03-29","changeNote":"Curated to support protocol BRN_LASR_79623_ghd_03.29.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6184950","version":"1","preferredName":"Metastatic Melanoma Anatomic Site","preferredDefinition":"The structure or organ within the body to which cancer (atypical neoplastic cells) originating in melanocytes (skin pigmenting cells) has spread from its original site.","longName":"MET_MEL_ANAT_SITE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69C2BD6E-9CD9-7690-E053-F662850AE2D1","latestVersionIndicator":"Yes","beginDate":"2018-04-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-13","modifiedBy":"HARTLEYG","dateModified":"2018-04-13","changeNote":"Curated to support Melanoma study_ghd_04.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242437","version":"1","preferredName":"Neoplasm Additional Mutation Abnormality Present Indicator","preferredDefinition":"The indication of whether or not additional tumor mutation abnormalities are present.","longName":"NEO_ADD_MUT_ABN_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B166282-1707-0C92-E053-F662850A690F","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242438","version":"1","preferredName":"Neoplasm Additional Mutation Abnormality Present Name","preferredDefinition":"The response that indicates the name of additional tumor mutations present.","longName":"NEO_MUT_ABN_PRES_NAM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B17C54F-C8CA-0CB2-E053-F662850A1294","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242439","version":"1","preferredName":"Post Disease Progression Therapeutic Procedure Informed Consent Obtain Date","preferredDefinition":"The date the patient consented to receive therapy after disease progression occurs.","longName":"PST_DZPROG_TX_CON_DT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B16C390-3D0F-7CCA-E053-F662850A86E9","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242440","version":"1","preferredName":"Post Disease Progression Therapeutic Procedure Informed Consent Obtain Indicator","preferredDefinition":"The indication of whether or not a patient has consented to receive therapy after disease progression.","longName":"PST_DZPRG_TX_CON_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B16E317-B6C7-7FA5-E053-F662850A6A9E","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242442","version":"1","preferredName":"Post Disease Progression Therapeutic Procedure Informed Consent Not Obtained Reason","preferredDefinition":"The text response that indicates the reason that a patient was not consented to received therapy after disease progression occurred.","longName":"PS_DZPR_TX_NTCON_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B17F7E3-63A1-0BAC-E053-F662850ACD21","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242443","version":"1","preferredName":"Post Disease Progression Therapeutic Procedure Administered Indicator","preferredDefinition":"The indication of whether or not treatment was given after disease progression.","longName":"TX_PS_DZPRO_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B17C54F-C8EB-0CB2-E053-F662850A1294","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242447","version":"1","preferredName":"Post Disease Progression Therapeutic Procedure Not Administered Reason","preferredDefinition":"The text response that provides the reason a patient did not receive treatment post disease progression.","longName":"PS_DZPR_TX_NTADM_RSN","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B168BAD-B179-0C9C-E053-F662850ABD2A","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242448","version":"1","preferredName":"ROS1 Gene Mutation Abnormality Analysis Performed Indicator","preferredDefinition":"The indication of whether or not ROS1 gene mutation analysis was performed.","longName":"ROS1_MUT_ABN_ANL_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B14979B-02AC-4A7E-E053-F662850A54A7","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242449","version":"1","preferredName":"PDL1 Mutation Abnormality Analysis Performed Indicator","preferredDefinition":"The indication or whether or not PDL-1 gene mutation analysis was performed.","longName":"PDL1_MUT_ANL_PRF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B17A069-078B-7FC7-E053-F662850A9456","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242452","version":"1","preferredName":"PDL1 Mutation Abnormality Present Percentage Value","preferredDefinition":"The numeric response that indicates the percentage of PDL1 gene mutations present.","longName":"PDL1_MUT_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B176761-E0C1-0CAE-E053-F662850A69D8","latestVersionIndicator":"Yes","beginDate":"2018-04-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-04-30","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_04.30.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242694","version":"1","preferredName":"Tumor Mutation Burden Analysis Performed Indicator","preferredDefinition":"The indication of whether or not a patient has had tumor mutational burden analysis performed.","longName":"TMB_ANAL_PRF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B299EB6-785A-5479-E053-F662850A6451","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-05-01","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_05.01.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6242695","version":"1","preferredName":"Tumor Mutational Burden Severity Grade","preferredDefinition":"The response indicating the severity of the tumor mutational burden.","longName":"TMB_SEV_GD","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B26B125-E067-2DC3-E053-F662850AE36E","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-05-01","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_05.01.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6243872","version":"1","preferredName":"Neoplasm Mutation Abnormality Identification Number","preferredDefinition":"The numeric response that indicates the number of tumor mutations identified by analysis.","longName":"NEO_MUT_AGN_ID_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B2679CF-ED3C-02C5-E053-F662850A8BD7","latestVersionIndicator":"Yes","beginDate":"2018-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-05-01","modifiedBy":"HARTLEYG","dateModified":"2018-05-01","changeNote":"Curated to support TOP1705_ghd_05.1.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6379398","version":"1","preferredName":"Self-Report Headache Past 7 Day Occurrence Number","preferredDefinition":"The numerical response that indicates the number of headaches a patient reports that have occurred within the past 7 days.","longName":"SLFRPT_HDACH_7DY_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"72008753-C90F-483F-E053-F662850AA2DC","latestVersionIndicator":"Yes","beginDate":"2018-07-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-07-27","modifiedBy":"HARTLEYG","dateModified":"2018-07-27","changeNote":"Curated to support BRN_PVSRIPO_GRII/III_91222_ghd_07.27.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6379399","version":"1","preferredName":"Self-Report Seizure Past 7 Day Occurrence Number","preferredDefinition":"The numerical response that indicates the number of seizures a patient reports that have occurred within the past 7 days.","longName":"SLFRPT_SZR_7DY_NUM","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7200E918-610A-7E0E-E053-F662850AE1E6","latestVersionIndicator":"Yes","beginDate":"2018-07-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-07-27","modifiedBy":"HARTLEYG","dateModified":"2018-07-27","changeNote":"Curated to support BRN_PVSRIPO_GRII/III_91222_ghd_07.27.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6596689","version":"1","preferredName":"Oxygen Uptake Absolute Value Rate","preferredDefinition":"The numeric response that indicates the rate of oxygen consumption measured in L/min during incremental exercise.","longName":"OXY_UP_ABS_VAL_RT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D63F341-CCC5-098C-E053-F662850A7C00","latestVersionIndicator":"Yes","beginDate":"2018-12-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-12-19","modifiedBy":"HARTLEYG","dateModified":"2018-12-19","changeNote":"Curated for DCI_12.19.18_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6730798","version":"1","preferredName":"Laboratory Procedure During Patient Visit Reticulocyte Count Performed Indicator","preferredDefinition":"The response indicating whether or not a reticulocyte count was performed during the patient visit.","longName":"RET_COUNT_PRF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8761BCFC-329F-3398-E053-F662850A5327","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-04-25","changeNote":"Curated to support BRS_GMI-1359-210_101977","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6813976","version":"1","preferredName":"Fagotti Total Score","preferredDefinition":"The sum of the predictive index values assigned to the inclusion criteria that make up the Fagotti score.","longName":"FAGOTTI_TTL_SCR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2BFF18-58F1-565E-E053-F662850A19C4","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-08","modifiedBy":"COOPERM","dateModified":"2019-07-08","changeNote":"Created for Duke request related to GYN_Atezo_79313 study. 7.3.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6849033","version":"1","preferredName":"Patient Clinical Benefits Result Specify","preferredDefinition":"The text response associated with a clinically positive outcome for a person who receives medical attention, care, or treatment in connection with a clinical trial.","longName":"PT_CLIN_BENF_RSL_SFY","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF0119F-8015-45A9-E053-F662850A62F6","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-12","modifiedBy":"HARTLEYG","dateModified":"2019-08-12","changeNote":"Curated to support BRS_GMI_1359_20_101977","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6862466","version":"1","preferredName":"WHO Follicular Lymphoma Histologic Grading System Disease Response Grade","preferredDefinition":"The histologic grade of follicular lymphoma based on the 2008 World Health Organization classification.","longName":"WHO_FOLL_LYMP_GRADE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CBD492-6375-4BDC-E053-F662850ABE4D","latestVersionIndicator":"Yes","beginDate":"2019-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-23","modifiedBy":"HARTLEYG","dateModified":"2019-08-23","changeNote":"Curated to support Protocol HEME_REMD477_102920","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931149","version":"1","preferredName":"Study Subject Data Analysis Dataset Eligible Indicator","preferredDefinition":"The indication of whether the subject's data is evaluable for data analysis.","longName":"SUBJ_ANLYS_ELIG_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9275D338-64AF-31E8-E053-F662850A7CEA","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-09-13","modifiedBy":"HARTLEYG","dateModified":"2019-09-17","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961727","version":"1","preferredName":"Bladder Carcinoma Ureter Involvement Indicator","preferredDefinition":"Indication of whether or not there was ureter involvement in the bladder carcinoma.","longName":"BLD_CRCN_URT_INV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F68A0D-0066-15AB-E053-F662850A2F31","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support protocol GU_TRIOBLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961728","version":"1","preferredName":"Bladder Carcinoma Timepoint Disease Response Status","preferredDefinition":"The response indicating the disease response status of the patient with bladder carcinoma at an indicated time point.","longName":"BLD_CRCN_DS_RSP_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F51596-CAEE-7B0D-E053-F662850AAD09","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support protocol GU_TRIOBLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961729","version":"1","preferredName":"Intravesical Route of Administration Chemotherapy Administered Indicator","preferredDefinition":"Indication as to whether or not chemotherapy was administered using an intravesical route of administration.","longName":"ITVC_CHEM_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F657E6-2F96-15B3-E053-F662850A1D10","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961730","version":"1","preferredName":"Intravesical Route of Administration Chemotherapy Administered Type","preferredDefinition":"The response indicating the chemotherapy agent administered via an intravesical route of administration.","longName":"ITVC_CHEM_ADM_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F6BA9E-BA3A-6C6A-E053-F662850A7805","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961733","version":"1","preferredName":"Medical Device During Intravesical Route of Administration Chemotherapy Hyperthermia Induction Indicator","preferredDefinition":"The indication of whether or not a medical device was used to induce hyperthermia during the intravesical administration of chemotherapy.","longName":"DVC_IVS_CX_HYPT_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F6E64B-E5CF-15AF-E053-F662850A8DF8","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6961736","version":"1","preferredName":"Medical Device During Intravesical Route of Administration Chemotherapy Hyperthermia Induction Type","preferredDefinition":"The response describing the type of hyperthermia system used during intravesical chemotherapy administration.","longName":"DVC_IVS_CX_HYPT_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F6F9DA-D59E-15A5-E053-F662850A9E88","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-02","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6962714","version":"1","preferredName":"Cisplatin Agent Administration Eligible Indicator","preferredDefinition":"The indication of whether or not the patient is eligible to receive cisplatin.","longName":"CSPL_AGT_ADM_ELG_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94049CC9-DF06-6118-E053-F662850A8E4F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-03","modifiedBy":"HARTLEYG","dateModified":"2019-10-03","changeNote":"Curated to support DCI protocol","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6968133","version":"1","preferredName":"Bladder Carcinoma Decipher Cancer Assay Molecular Subtype Classification Type","preferredDefinition":"The response that indicates the molecular subtype of bladder carcinoma determined using a Decipher Bladder Assay.","longName":"BLD_CRCN_ML_STYP_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94190C73-A042-431B-E053-F662850AF46A","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6968147","version":"1","preferredName":"Bladder Carcinoma BCG Vaccine Disease Response Status","preferredDefinition":"The response indicating the disease status after treatment with the BCG vaccine.","longName":"BCG_DSZ_RSP_ST","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9417D760-A2E9-2DF6-E053-F662850AE168","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6968148","version":"1","preferredName":"Transurethral Resection of Bladder Tumor Complete Indicator","preferredDefinition":"The response indicating whether or not the transurethral resection of the bladder tumor was completed.","longName":"TURBT_CMPL_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9417D760-A30A-2DF6-E053-F662850AE168","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6968149","version":"1","preferredName":"Prostatic Urethra Involvement Indicator","preferredDefinition":"The response that indicates whether or not the prostatic urethra was involved.","longName":"PSTC_URTA_INV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"941831A1-807F-2E02-E053-F662850AAE4D","latestVersionIndicator":"Yes","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"HARTLEYG","dateModified":"2019-10-04","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6974958","version":"1","preferredName":"Bladder Carcinoma Surgical Procedure Performed Indicator","preferredDefinition":"The response indicating whether or not the protocol defined surgical procedure for bladder carcinoma was performed.","longName":"BDCRCN_SURG_PRF_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9481900E-D7AF-1E48-E053-F662850AE26B","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"HARTLEYG","dateModified":"2019-10-10","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6974959","version":"1","preferredName":"Bladder Carcinoma Surgical Procedure Performed Type","preferredDefinition":"The response indicating the type of surgical procedure performed for bladder carcinoma.","longName":"BDCRCN_SURG_PRF_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9481A88A-8C0D-2EF5-E053-F662850A7885","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"HARTLEYG","dateModified":"2019-10-10","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7038312","version":"1","preferredName":"Prostatic Urethra Involvement Indicator","preferredDefinition":"The response that indicates whether or not the prostatic urethra was involved.","longName":"PSTC_URTR_INV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"964DCDD9-8FBF-0C18-E053-F662850ADD27","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"HARTLEYG","dateModified":"2019-11-01","changeNote":"Curated to support GU_TRIO_BLADDER_102352","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7062863","version":"1","preferredName":"Metastatic Brain Tumor Radiation Administered Indicator","preferredDefinition":"The indication of whether or not a patient received brain radiation for metastatic brain lesions.","longName":"MET_BRN_RAD_ADM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97BC09DC-E583-700B-E053-F662850A9594","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-19","modifiedBy":"HARTLEYG","dateModified":"2019-11-22","changeNote":"Curated to support TOP_1901_103723","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7062864","version":"1","preferredName":"Osimertinib Last Systemic Therapy Prior Enrollment Administered Indicator","preferredDefinition":"The indication of whether or not Osimertinib was the last systemic therapy administered to the patient prior to enrollment.","longName":"OSMR_SYTX_PR_ENR_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97BAF047-2BD9-58C6-E053-F662850AA214","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-19","modifiedBy":"HARTLEYG","dateModified":"2019-11-22","changeNote":"Curated to support TOP_1901_103723","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7283839","version":"1","preferredName":"Acute Lymphoblastic Leukemia Central Nervous System Involvement Indicator","preferredDefinition":"The indicator that describes whether or not there was acute lymphoblastic leukemia central nervous system involvement.","longName":"ALL_CNS_INV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5107838-3E56-3A80-E053-F662850A1E80","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-07","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7283843","version":"1","preferredName":"Lymphomatous Extramedullary Involvement Indicator","preferredDefinition":"The indicator that describes the status of lymphomatous extramedullary involvement.","longName":"LYM_EM_INV_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A50FE757-5A08-7828-E053-F662850A0232","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-07","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7283857","version":"1","preferredName":"Acute Lymphoblastic Leukemia Best Disease Response Evaluation Status","preferredDefinition":"A description of the acute lymphoblastic leukemia best disease response evaluation status.","longName":"ALL_BST_DIS_RSP_EVAL_STS","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A50FC3C9-9513-784F-E053-F662850A8F1F","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-07","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7283859","version":"1","preferredName":"Specimen Cerebrospinal Fluid Collection Method Name","preferredDefinition":"A description of the cerebrospinal fluid specimen collection method.","longName":"SPEC_CSF_COLL_METH","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5138721-AF4E-4248-E053-F662850A450E","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-07","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7290187","version":"1","preferredName":"Lymphoblast Laboratory Procedure Bone Marrow Performed Total Cell Count","preferredDefinition":"The total count of lymphoblasts in the bone marrow.","longName":"LBLST_LAB_BM_TTL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A565307F-3A0F-37BC-E053-F662850A74C1","latestVersionIndicator":"Yes","beginDate":"2020-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-11","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7290679","version":"1","preferredName":"Lymphoblast Laboratory Procedure Bone Marrow Performed Percentage Value","preferredDefinition":"The 1 decimal place numeric percentage value related to the assessment of lymphoblasts in the bone marrow.","longName":"LBLST_BM_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A565798D-35C4-43CC-E053-F662850A4740","latestVersionIndicator":"Yes","beginDate":"2020-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-11","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7290697","version":"1","preferredName":"Myeloblast Laboratory Procedure Bone Marrow Performed Total Cell Count","preferredDefinition":"The total count of myeloblasts in the bone marrow.","longName":"MBLST_LAB_BM_TTL_CT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5648F26-9B70-4253-E053-F662850A4DA2","latestVersionIndicator":"Yes","beginDate":"2020-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-11","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7290698","version":"1","preferredName":"Myeloblast Laboratory Procedure Bone Marrow Performed Percentage Value","preferredDefinition":"The 1 decimal place numeric percentage value related to the assessment of myeloblasts in the bone marrow.","longName":"MBLST_BM_PCT_VAL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5657E16-DCE0-4322-E053-F662850ABB05","latestVersionIndicator":"Yes","beginDate":"2020-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-11","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7290746","version":"1","preferredName":"Acute Lymphoblastic Leukemia Prior Treatment Regimen Administered Type","preferredDefinition":"A description of the acute lymphoblastic leukemia prior treatment regimen that was administered.","longName":"ALL_PR_TX_REG_ADMIN_TYPE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5649DAE-FCEC-3C68-E053-F662850A9DC3","latestVersionIndicator":"Yes","beginDate":"2020-05-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-11","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7292189","version":"1","preferredName":"Acute Lymphoblastic Leukemia Classification ALL Type","preferredDefinition":"A description of the acute lymphoblastic leukemia classification type.","longName":"ALL_CLASS_ALL_TYPE","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58AD989-9E44-01C2-E053-F662850A3C21","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307653","version":"1","preferredName":"NCCN Risk Stratification Acute Lymphoblastic Leukemia Category","preferredDefinition":"A description of the NCCN risk stratification for acute lymphoblastic leukemia.","longName":"NCCN_RSK_STRAT_ALL_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A26111-9C04-71DA-E053-4EBD850A3540","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307664","version":"1","preferredName":"NCCN Cytogenetic Risk Group for ALL Initial Diagnosis Category","preferredDefinition":"A description of the NCCN cytogenetic risk group for ALL initial diagnosis.","longName":"NCCN_CYTO_RSK_GP_ALL_DX_CAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A05823-C138-2379-E053-4EBD850A4FE1","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307764","version":"1","preferredName":"Disease Status NCCN ALL Response Criterion Blood And Bone Marrow Type","preferredDefinition":"A description of the NCCN ALL disease response criteria for blood and bone marrow.","longName":"DIS_NCCN_ALL_RSP_CRT_BL_BM_TY","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A3AD22-4CE9-7C18-E053-4EBD850AD3D2","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307861","version":"1","preferredName":"Disease Status NCCN ALL Response Criterion CNS Disease Type","preferredDefinition":"A description of the NCCN ALL disease response criteria for CNS disease.","longName":"DIS_NCCN_ALL_RSP_CRT_CNS_TY","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A40FCA-3181-0ECE-E053-4EBD850A4043","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307904","version":"1","preferredName":"Disease Status NCCN ALL Response Criterion Lymphomatous Extramedullary Disease Type","preferredDefinition":"A description of the NCCN ALL disease response criteria for lymphomatous extramedullary disease.","longName":"DIS_NCCN_ALL_RSP_CRT_LED_TY","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A45CC5-6A24-316A-E053-4EBD850A5BCD","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7307944","version":"1","preferredName":"Lab Test Assessment Method Type","preferredDefinition":"A description of the lab test assessment method.","longName":"LAB_TEST_ASSMT_METH","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A4C876-EF07-4544-E053-4EBD850A115E","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"KUMMEROA","dateModified":"2020-05-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651597","version":"1","preferredName":"D2C7 IHC Result Status","preferredDefinition":"Text term that represents the status of the D2C7-IT Receptor Immunohistochemistry (IHC) result or reason for the lack of a result.","longName":"D2C7_IHC_RSLT_STAT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1868E03-A408-3247-E053-4EBD850AEEA6","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-05","changeNote":"Created for Duke DUHS D2C7 IHC. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651598","version":"1","preferredName":"D2C7 IHC Staining Score","preferredDefinition":"Numeric score to describe the result of immunohistochemical (IHC) testing of D2C7 Score.","longName":"D2C7_IHC_STAIN_SCR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C186C02D-8CB6-64D6-E053-4EBD850AB4A0","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-05","changeNote":"Created for Duke DUHS D2C7 IHC. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651603","version":"1","preferredName":"Two or More New Bone Lesions Since Follow-up Bone Scan Occurrence Indicator","preferredDefinition":"Text indicator to signify whether or not 2 or more new bone lesions were identified since the follow-up bone scan.","longName":"GTET_2_NW_BN_LS_OCC","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C186F86A-11CA-0837-E053-4EBD850A2025","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-04","changeNote":"Created for PCCTC Bone Scan Assessment. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651608","version":"1","preferredName":"First Bone Scan Post Follow-up Bone Scan Performed Indicator","preferredDefinition":"Text indicator to signify whether this is the 1st bone scan performed post the follow-up bone scan.","longName":"1ST_BS_PST_FU_BS_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1867921-317F-6276-E053-4EBD850A57BB","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-04","changeNote":"Created for PCCTC Bone Scan Assessment. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651611","version":"1","preferredName":"Two or More New Bone Lesions Since Baseline Bone Scan Occurrence Indicator","preferredDefinition":"Text indicator to signify whether 2 of more new lesions since baseline bone scan occurred.","longName":"GTET_2_NW_BL_SNC_BL","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C18744D9-00FF-1D84-E053-4EBD850A55BD","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-04","changeNote":"Created for PCCTC Bone Scan Assessment. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651619","version":"1","preferredName":"Two or More New Bone Lesions Since Previous Bone Scan Confirmation Indicator","preferredDefinition":"Text indicator to signify whether 2 or more new lesions were confirmed since the previous bone scan.","longName":"GTET_2_NW_BL_CFRM_IND","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1876698-C761-19E0-E053-4EBD850A8500","latestVersionIndicator":"Yes","beginDate":"2021-05-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-04","modifiedBy":"KUMMEROA","dateModified":"2021-05-04","changeNote":"Created for  PCCTC Bone Scan Assessment. 2021-5-4 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651640","version":"1","preferredName":"D2C7 1+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric percentage value of D2C7 staining 1+ by immunohistochemical (IHC) methods.","longName":"D2C7_1_STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C194406B-639E-7510-E053-4EBD850A3833","latestVersionIndicator":"Yes","beginDate":"2021-05-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-05","modifiedBy":"KUMMEROA","dateModified":"2021-05-05","changeNote":"Created for DUHS D2C7 IHC. 2021-5-5 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651641","version":"1","preferredName":"D2C7 2+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric percentage value of D2C7 staining 2+ by immunohistochemical (IHC) methods.","longName":"D2C7_2_STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C194674E-7D95-751B-E053-4EBD850A0F70","latestVersionIndicator":"Yes","beginDate":"2021-05-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-05","modifiedBy":"KUMMEROA","dateModified":"2021-05-05","changeNote":"Created for DUHS D2C7 IHC. 2021-5-5 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7651642","version":"1","preferredName":"D2C7 3+ PVR Stain Result Percentage Integer","preferredDefinition":"Numeric percentage value of D2C7 staining 3+ by immunohistochemical (IHC) methods.","longName":"D2C7_3_STN_PRCNT_INTGR","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1946DA3-A79A-751D-E053-4EBD850A34D0","latestVersionIndicator":"Yes","beginDate":"2021-05-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-05-05","modifiedBy":"KUMMEROA","dateModified":"2021-05-05","changeNote":"Created for DUHS D2C7 IHC. 2021-5-5 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7716350","version":"1","preferredName":"Target Lesion Percent Change From Baseline in Sum of Diameter Text","preferredDefinition":"A description of the sum of diameter size percentage change on target lesions compared to baseline.","longName":"TRG_LS_BSL_SUM_DIAM_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6104806-0132-2EC5-E053-4EBD850A390D","latestVersionIndicator":"Yes","beginDate":"2021-07-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-01","modifiedBy":"KUMMEROA","dateModified":"2021-07-01","changeNote":"2021-7-1 ak Created for Duke.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7716354","version":"1","preferredName":"Target Lesion Percent Change From Nadir in Sum of Diameter Text","preferredDefinition":"A description of the sum of diameter size percentage change on target lesions compared to nadir.","longName":"TRG_LS_NDR_SUM_DIAM_TXT","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F3AAB-7915-0C71-E053-4EBD850AF757","latestVersionIndicator":"Yes","beginDate":"2021-07-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-01","modifiedBy":"KUMMEROA","dateModified":"2021-07-01","changeNote":"2021-7-1 ak Created for Duke.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7767202","version":"1","preferredName":"Melanoma Treatment Response Type","preferredDefinition":"Text term to describe the disease response for melanoma after treatment.","longName":"MEL_TRT_RSP_TYP","contextName":"DCI","contextVersion":"1","dataElementConceptPublicId":"2680508","dataElementConceptVersion":"1","valueDomainPublicId":"2838543","valueDomainVersion":"1.1","origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9C1046B-7DEA-7E90-E053-4EBD850A1F1E","latestVersionIndicator":"Yes","beginDate":"2021-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-08-17","modifiedBy":"KUMMEROA","dateModified":"2021-08-17","changeNote":"2021-8-17 ak Created for Duke.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}]}